The O O
differential O O
diagnosis O O
of O O
early O O
gastric B-Habitat B-Habitat
mucosa I-Habitat O
- O O
associated O O
lymphoma O O
: O O
polymerase O O
chain O O
reaction O O
and O O
paraffin O O
section O O
immunophenotyping O O
. O O

The O O
distinction O O
between O O
benign O B-Habitat
florid O I-Habitat
lymphoid O I-Habitat
hyperplasia O I-Habitat
and O O
low O O
- O O
grade O O
gastric B-Habitat O
mucosal I-Habitat O
- I-Habitat O
associated I-Habitat O
lymphoid I-Habitat O
tissue I-Habitat O
( O O
MALT B-Habitat O
) O O
lymphoma O O
may O O
be O O
a O O
challenge O O
. O O

The O O
presence O O
of O O
monoclonal B-Habitat B-Habitat
B I-Habitat I-Habitat
cells I-Habitat I-Habitat
in O O
Helicobacter B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
- O O
chronic O O
active O O
gastritis O O
has O O
suggested O O
that O O
polymerase O O
chain O O
reaction O O
( O O
PCR O O
) O O
data O O
should O O
be O O
viewed O O
with O O
caution O O
. O O

We O O
investigated O O
the O O
reliability O O
of O O
PCR O O
versus O O
immunophenotyping O O
in O O
diagnosing O O
early O O
gastric B-Habitat B-Habitat
MALT O I-Habitat
lymphoma O I-Habitat
. O O

We O O
studied O O
1511 O O
biopsies O O
from O O
eight O O
patients B-Habitat B-Habitat
with I-Habitat I-Habitat
high I-Habitat I-Habitat
- I-Habitat I-Habitat
grade I-Habitat I-Habitat
primary I-Habitat I-Habitat
gastric I-Habitat I-Habitat
lymphoma I-Habitat I-Habitat
, O I-Habitat
25 O I-Habitat
with O I-Habitat
low O I-Habitat
- O I-Habitat
grade O I-Habitat
MALT B-Habitat I-Habitat
lymphoma O I-Habitat
, O O
32 O O
with O O
atypical O O
lymphoid O O
infiltrates O O
, O O
and O O
39 O O
with O O
Helicobacter B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
- O O
chronic O O
active O O
gastritis O O
. O O

Paraffin O O
sections O O
from O O
all O O
cases O O
were O O
stained O O
with O O
antibodies O O
to O O
CD20 B-Habitat O
, O O
CD3 B-Habitat O
, O O
AE1 O O
/ O O
AE3 O O
, O O
kappa O O
and O O
lambda O O
. O O

PCR O O
was O O
performed O O
on O O
paraffin O B-Habitat
sections O I-Habitat
using O O
the O O
primer O O
set O O
VH O O
- O O
FR3 O O
/ O O
J O O
( O O
H O O
) O O
. O O

Using O O
histopathology O O
as O O
the O O
gold O O
standard O O
in O O
diagnosis O O
, O O
we O O
confirmed O O
monoclonality O O
in O O
22 O O
of O O
25 O O
MALT B-Habitat O
lymphomas O O
( O O
88 O O
% O O
) O O
; O O
a O O
clonal O O
band O O
was O O
found O O
in O O
38 O O
% O O
( O O
15 O O
of O O
39 O O
) O O
of O O
patients B-Habitat B-Habitat
with I-Habitat I-Habitat
chronic I-Habitat I-Habitat
active I-Habitat I-Habitat
gastritis I-Habitat I-Habitat
. O O

An O O
immunophenotype O O
pattern O O
with O O
predominance O O
of O O
CD20 B-Habitat O
- I-Habitat O
positive I-Habitat O
cells I-Habitat O
in O O
lymphocytic B-Habitat O
infiltrates O O
was O O
associated O O
with O O
monoclonality O O
in O O
92 O O
% O O
of O O
cases O O
. O O

The O O
presence O O
of O O
an O O
enlarged O O
irregular O O
mantle O O
zone O O
was O O
found O O
in O O
both O O
monoclonal O O
and O O
polyclonal O O
areas O O
. O O

An O O
equal O O
prevalence O O
of O O
B O O
and O O
T B-Habitat B-Habitat
cells I-Habitat I-Habitat
in O O
lymphocytic B-Habitat O
infiltrates O O
was O O
associated O O
with O O
a O O
polyclonal O O
pattern O O
in O O
24 O O
of O O
31 O O
cases O O
( O O
77 O O
% O O
) O O
. O O

Immunostaining O O
of O O
sIg O O
( O O
kappa O O
and O O
lambda O O
) O O
was O O
difficult O O
in O O
paraffin O B-Habitat
sections O I-Habitat
and O O
convincing O O
proof O O
of O O
monoclonality O O
was O O
not O O
obtained O O
. O O

Lymphoepithelial B-Habitat O
lesions I-Habitat O
were O O
infrequent O O
in O O
gastric B-Habitat B-Habitat
biopsies O I-Habitat
and O O
their O O
presence O O
was O O
highlighted O O
with O O
keratin O O
stains O O
. O O

Because O O
monoclonal B-Habitat B-Habitat
B I-Habitat I-Habitat
cells I-Habitat I-Habitat
are O O
observed O O
in O O
Helicobacter B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
- O O
associated O O
gastritis O O
, O O
the O O
correct O O
interpretation O O
of O O
clonality O O
by O O
PCR O O
remains O O
unclear O O
. O O

Paraffin O O
section O O
IHC O O
using O O
CD20 B-Habitat O
and O O
CD3 B-Habitat O
is O O
especially O O
useful O O
to O O
confirm O O
the O O
diagnosis O O
of O O
gastric B-Habitat B-Habitat
MALT O I-Habitat
lymphoma O I-Habitat
. O O

Evaluation O O
of O O
antibacterial O O
activity O O
of O O
synthetic O O
aliphatic O O
and O O
aromatic O O
monoacylglycerols O O
. O O

The O O
antibacterial O O
activity O O
of O O
synthetic O O
aliphatic O O
and O O
aromatic O O
monoacylglycerols O O
( O O
MAGs O O
) O O
was O O
studied O O
against O O
two O O
human B-Habitat B-Habitat
pathogens O O
: O O
Staphylococcus B-Bacteria B-Bacteria
aureus I-Bacteria I-Bacteria
and O O
Escherichia B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
. O O

The O O
active O O
compounds O O
inhibited O O
selectively O O
S B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
aureus I-Bacteria I-Bacteria
. O O

The O O
most O O
active O O
compounds O O
amongst O O
them O O
were O O
those O O
with O O
medium O O
size O O
aliphatic O O
chain O O
and O O
aromatic O O
MAGs O O
with O O
electron O O
withdrawing O O
substituents O O
at O O
the O O
aryl O O
ring O O
. O O

The O O
introduction O O
of O O
one O O
or O O
two O O
- O O
carbon O O
spacer O O
between O O
the O O
aryl O O
ring O O
and O O
the O O
carboxylic O O
function O O
did O O
not O O
influence O O
antibacterial O O
effectiveness O O
. O O

Isolation O O
, O O
expression O O
and O O
characterization O O
of O O
a O O
minor O O
allergen O O
from O O
Penicillium B-Habitat B-Habitat
crustosum I-Habitat I-Habitat
. O O

A O O
ribosomal O O
P1 O O
protein O O
, O O
Pen O O
b O O
26 O O
from O O
Penicillium B-Habitat B-Bacteria
brevicompactum I-Habitat I-Bacteria
, O O
was O O
previously O O
identified O O
as O O
a O O
major O O
allergen O O
. O O

A O O
homolog O O
protein O O
was O O
isolated O O
and O O
characterized O O
from O O
Penicillium B-Habitat B-Bacteria
crustosum I-Habitat I-Bacteria
which O O
is O O
not O O
known O O
to O O
be O O
allergenic O O
mold O O
. O O

A O O
cDNA O O
library O O
of O O
P B-Habitat B-Bacteria
. I-Habitat I-Bacteria
Habitat_I I-Habitat I-Bacteria
crustosum I-Habitat I-Bacteria
was O O
constructed O O
and O O
screened O O
using O O
a O O
probe O O
based O O
on O O
the O O
DNA O O
sequence O O
of O O
Pen O O
b O O
26 O O
. O O

A O O
positive O O
clone O O
was O O
isolated O O
, O O
expressed O O
in O O
Escherichia B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
, O O
purified O O
and O O
characterized O O
by O O
comparing O O
its O O
immunological O O
and O O
physical O O
properties O O
to O O
Pen O O
b O O
26 O O
. O O

It O O
was O O
designated O O
as O O
Pen O O
cr O O
26 O O
and O O
had O O
a O O
321 O O
nt O O
ORF O O
corresponding O O
to O O
107 O O
amino O O
acids O O
with O O
a O O
MW O O
of O O
11 O O
O O O
kDa O O
. O O

Pen O O
cr O O
26 O O
had O O
strong O O
sequence O O
homology O O
to O O
Pen O O
b O O
26 O O
( O O
92 O O
% O O
for O O
nucleotides O O
and O O
86 O O
% O O
for O O
amino O O
acids O O
) O O
and O O
its O O
physical O O
and O O
predicted O O
structural O O
properties O O
were O O
similar O O
to O O
the O O
latter O O
. O O

The O O
level O O
of O O
expression O O
of O O
Pen O O
cr O O
26 O O
was O O
much O O
lower O O
than O O
that O O
of O O
Pen O O
b O O
26 O O
in O O
the O O
same O O
expression O O
vector O O
. O O

Both O O
proteins O O
were O O
recognized O O
equally O O
well O O
by O O
the O O
IgG O O
class O O
specific O O
antibodies O O
, O O
but O O
Pen O O
cr O O
26 O O
was O O
poorly O O
recognized O O
by O O
Penicillium B-Habitat O
- I-Habitat O
sensitive I-Habitat O
atopic I-Habitat O
sera I-Habitat O
( O O
IgE O O
) O O
, O O
suggesting O O
striking O O
antigenic O O
difference O O
in O O
IgE O O
epitopes O O
, O O
i O O
. O O
e O O
. O O
, O O
87 O O
% O O
were O O
positive O O
for O O
Pen O O
b O O
26 O O
while O O
only O O
23 O O
% O O
were O O
positive O O
for O O
Pen O O
cr O O
26 O O
. O O

The O O
allergenicity O O
of O O
Pen O O
cr O O
26 O O
seems O O
to O O
be O O
minor O O
in O O
nature O O
and O O
it O O
could O O
be O O
a O O
hypoallergenic O O
variant O O
of O O
Pen O O
b O O
26 O O
. O O

Rickettsia B-Bacteria B-Bacteria
infection O O
in O O
five O O
areas O O
of O O
the O O
state O O
of O O
São O B-Bacteria
Paulo O I-Bacteria
, O O
Brazil O O
. O O

This O O
study O O
investigated O O
rickettsial B-Bacteria O
infection O O
in O O
animals B-Habitat B-Habitat
, O O
humans B-Habitat B-Habitat
, O O
ticks B-Habitat O
, O O
and O O
fleas B-Habitat O
collected O O
in O O
five O O
areas O O
of O O
the O O
state O O
of O O
São O O
Paulo O O
. O O

Eight O O
flea B-Habitat O
species O O
( O O
Adoratopsylla B-Habitat O
antiquorum I-Habitat O
antiquorum I-Habitat O
, O O
Ctenocephalides B-Habitat B-Habitat
felis I-Habitat I-Habitat
felis I-Habitat I-Habitat
, O O
Polygenis B-Habitat O
atopus I-Habitat O
, O O
Polygenis B-Habitat O
rimatus I-Habitat O
, O O
Polygenis B-Habitat O
roberti I-Habitat O
roberti I-Habitat O
, O O
Polygenis B-Habitat O
tripus I-Habitat O
, O O
Rhopalopsyllus B-Habitat B-Bacteria
lugubris I-Habitat I-Bacteria
, O O
and O O
Rhopalopsyllus B-Habitat B-Habitat
lutzi I-Habitat I-Habitat
lutzi I-Habitat I-Habitat
) O O
, O O
and O O
five O O
tick B-Habitat O
species O O
( O O
Amblyomma B-Habitat O
aureolatum I-Habitat O
, O O
Amblyomma B-Habitat O
cajennense I-Habitat O
, O O
Amblyomma B-Habitat B-Bacteria
dubitatum I-Habitat I-Bacteria
, O O
Ixodes B-Habitat O
loricatus I-Habitat O
, O O
and O O
Rhipicephalus B-Habitat B-Bacteria
sanguineus I-Habitat I-Bacteria
) O O
were O O
collected O O
from O O
dogs B-Habitat O
, O O
cats B-Habitat O
, O O
and O O
opossums B-Habitat O
. O O

Rickettsia B-Bacteria B-Bacteria
felis I-Bacteria I-Bacteria
was O O
the O O
only O O
rickettsia B-Bacteria O
found O O
infecting O O
fleas B-Habitat O
, O O
whereas O O
Rickettsia B-Bacteria O
bellii I-Bacteria O
was O O
the O O
only O O
agent O O
infecting O O
ticks B-Habitat O
, O O
but O O
no O O
animal B-Habitat O
or O O
human B-Habitat B-Habitat
blood I-Habitat I-Habitat
was O O
shown O O
to O O
contain O O
rickettsial B-Bacteria O
DNA O O
. O O

Testing O O
animal B-Habitat O
and O O
human B-Habitat B-Habitat
sera O I-Habitat
by O O
indirect O O
immunofluorescence O O
assay O O
against O O
four O O
rickettsia B-Bacteria O
antigens O O
( O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
rickettsii I-Bacteria I-Bacteria
, O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
parkeri I-Bacteria I-Bacteria
, O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
felis I-Bacteria I-Bacteria
, O O
and O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
bellii I-Bacteria I-Bacteria
) O O
, O O
some O O
opossum B-Habitat O
, O O
dog B-Habitat O
, O O
horse B-Habitat O
, O O
and O O
human B-Habitat B-Habitat
sera O I-Habitat
reacted O O
to O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
rickettsii I-Bacteria I-Bacteria
with O O
titers O O
at O O
least O O
four O O
- O O
fold O O
higher O O
than O O
to O O
the O O
other O O
three O O
rickettsial B-Bacteria O
antigens O O
. O O

These O O
sera B-Habitat O
were O O
considered O O
to O O
have O O
a O O
predominant O O
antibody O O
response O O
to O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
rickettsii I-Bacteria I-Bacteria
. O O

Using O O
the O O
same O O
criteria O O
, O O
opossum B-Habitat O
, O O
dog B-Habitat O
, O O
and O O
horse B-Habitat O
sera I-Habitat O
showed O O
predominant O O
antibody O O
response O O
to O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
parkeri I-Bacteria I-Bacteria
or O O
a O O
very O O
closely O O
related O O
genotype O O
. O O

Our O O
serological O O
results O O
suggest O O
that O O
both O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
rickettsii I-Bacteria I-Bacteria
and O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
parkeri I-Bacteria I-Bacteria
infected O I-Bacteria
animals B-Habitat I-Bacteria
and O O
/ O O
or O O
humans B-Habitat B-Habitat
in O O
the O O
studied O O
areas O O
. O O

Iron O O
transport O O
in O O
the O O
genus O O
Marinobacter B-Bacteria B-Bacteria
. O O

Marinobacter B-Bacteria B-Bacteria
belong O I-Bacteria
to O O
the O O
class O O
of O O
Gammaproteobacteria B-Bacteria B-Bacteria
and O O
these O O
motile O O
, O O
halophilic O O
or O O
halotolerent O O
bacteria O O
are O O
widely O O
distributed O O
throughout O O
the O O
world B-Habitat O
' I-Habitat O
s I-Habitat O
oceans I-Habitat O
having O O
been O O
isolated O O
from O O
a O O
wide O O
variety O O
of O O
marine B-Habitat B-Habitat
environments I-Habitat O
. O O

They O O
have O O
also O O
been O O
identified O O
as O O
members O O
of O O
the O O
bacterial B-Habitat O
flora I-Habitat O
associated O O
with O O
other O O
marine B-Habitat B-Habitat
organisms I-Habitat I-Habitat
. O O

Here O O
, O O
using O O
a O O
combination O O
of O O
natural O B-Habitat
products O I-Habitat
chemistry O I-Habitat
and O O
genomic O O
analysis O O
, O O
we O O
assess O O
the O O
nature O O
of O O
the O O
siderophores O O
produced O O
by O O
this O O
genus O O
and O O
their O O
potential O O
relationship O O
to O O
phylogeny O O
and O O
lifestyle O O
/ O O
ecological O O
niche O O
of O O
this O O
diverse O O
group O O
of O O
organisms O O
. O O

Our O O
analysis O O
shows O O
a O O
wide O O
level O O
of O O
diversity O O
in O O
siderophore O O
based O O
iron O O
uptake O O
systems O O
among O O
this O O
genus O O
with O O
three O O
general O O
strategies O O
: O O
( O O
1 O O
) O O
production O O
and O O
utilization O O
of O O
native O O
siderophores O O
in O O
addition O O
to O O
utilization O O
of O O
a O O
variety O O
of O O
exogenous O O
ones O O
, O O
( O O
2 O O
) O O
production O O
and O O
utilization O O
of O O
native O O
siderophores O O
only O O
, O O
( O O
3 O O
) O O
lack O O
of O O
siderophore O O
production O O
but O O
utilization O O
of O O
exogenous O O
ones O O
. O O

They O O
all O O
share O O
the O O
presence O O
of O O
at O O
least O O
one O O
siderophore O O
- O O
independent O O
iron O O
uptake O O
ABC O O
transport O O
systems O O
of O O
the O O
FbpABC O O
iron O O
metal O O
type O O
and O O
lack O O
the O O
ability O O
for O O
direct O O
transport O O
of O O
ferrous O O
iron O O
. O O

Siderophore O O
production O O
and O O
utilization O O
can O O
be O O
correlated O O
with O O
phylogeny O O
and O O
thus O O
it O O
forms O O
a O O
type O O
of O O
chemotaxonomic O O
marker O O
for O O
this O O
genus O O
. O O

Ampicillin O O
- O O
resistant O O
Haemophilus B-Bacteria B-Bacteria
influenzae I-Bacteria I-Bacteria
type I-Bacteria I-Bacteria
B I-Bacteria I-Bacteria
possessing O O
a O O
TEM O O
- O O
type O O
beta O O
- O O
lactamase O O
but O O
little O O
permeability O O
barrier O O
to O O
ampicillin O O
. O O

Ampicillin O O
- O O
resistant O O
Haemophilus B-Bacteria B-Bacteria
influenzae I-Bacteria I-Bacteria
type I-Bacteria I-Bacteria
B I-Bacteria I-Bacteria
have O O
been O O
reported O O
only O O
during O O
the O O
past O O
year O O
. O O

Five O O
clinical B-Habitat O
isolates O O
from O O
the O O
U O B-Bacteria
. O I-Bacteria
S O I-Bacteria
. O O
and O O
Germany O O
all O O
had O O
the O O
TEM O O
- O O
type O O
beta O O
- O O
lactamase O O
which O O
is O O
known O O
to O O
be O O
transferred O O
widely O O
among O O
other O O
gram O O
- O O
negative O O
bacilli O O
. O O

Unlike O O
those O O
bacilli O O
, O O
however O O
, O O
the O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
influenzae I-Bacteria I-Bacteria
cell O O
had O O
very O O
little O O
barrier O O
to O O
entry O O
of O O
penicillins O O
. O O

This O O
greater O O
permeability O O
of O O
the O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
influenzae I-Bacteria I-Bacteria
cell O O
to O O
penicillins O O
appeared O O
to O O
reduce O O
the O O
protective O O
effect O O
of O O
its O O
beta O O
- O O
lactamase O O
, O O
in O O
that O O
acquisition O O
of O O
the O O
TEM O O
- O O
type O O
beta O O
- O O
lactamase O O
increased O O
levels O O
of O O
resistance O O
to O O
penicillins O O
much O O
less O O
for O O
individual O O
cells O O
of O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
influenzae I-Bacteria I-Bacteria
than O O
for O O
those O O
of O O
Escherichia B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
. O O

Large O O
inocula O O
of O O
either O O
species O O
appeared O O
highly O O
resistant O O
. O O

The O O
unusually O O
low O O
level O O
of O O
resistance O O
of O O
individual O O
cells O O
of O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
influenzae I-Bacteria I-Bacteria
containing O O
the O O
TEM O O
- O O
type O O
beta O O
- O O
lactamase O O
may O O
have O O
delayed O O
their O O
emergence O O
or O O
recognition O O
, O O
and O O
has O O
unresolved O O
clinical O O
implications O O
. O O

A O O
novel O O
receptor O O
- O O
ligand O O
pathway O O
for O O
entry O O
of O O
Francisella B-Bacteria B-Bacteria
tularensis I-Bacteria I-Bacteria
in O O
monocyte B-Habitat O
- I-Habitat O
like I-Habitat O
THP I-Habitat B-Habitat
- I-Habitat I-Habitat
1 I-Habitat I-Habitat
cells I-Habitat I-Habitat
: O O
interaction O O
between O O
surface O O
nucleolin O O
and O O
bacterial O O
elongation O O
factor O O
Tu O O
. O O

Francisella B-Bacteria B-Bacteria
tularensis I-Bacteria I-Bacteria
, O O
the O O
causative O O
agent O O
of O O
tularemia O O
, O O
is O O
one O O
of O O
the O O
most O O
infectious O O
human B-Habitat O
bacterial O O
pathogens O O
. O O

It O O
is O O
phagocytosed O O
by O O
immune B-Habitat B-Habitat
cells I-Habitat I-Habitat
, O I-Habitat
such O I-Habitat
as O I-Habitat
monocytes B-Habitat I-Habitat
and O O
macrophages B-Habitat O
. O O

The O O
precise O O
mechanisms O O
that O O
initiate O O
bacterial O O
uptake O O
have O O
not O O
yet O O
been O O
elucidated O O
. O O

Participation O O
of O O
C3 O O
, O O
CR3 O O
, O O
class O O
A O O
scavenger O O
receptors O O
and O O
mannose O O
receptor O O
in O O
bacterial O O
uptake O O
have O O
been O O
already O O
reported O O
. O O

However O O
, O O
contribution O O
of O O
an O O
additional O O
, O O
as O O
- O O
yet O O
- O O
unidentified O O
receptor O O
for O O
F B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
tularensis I-Bacteria I-Bacteria
internalization O O
has O O
been O O
suggested O O
. O O

We O O
show O O
here O O
that O O
cell B-Habitat O
- O O
surface O O
expressed O O
nucleolin O O
is O O
a O O
receptor O O
for O O
Francisella B-Bacteria B-Bacteria
tularensis I-Bacteria I-Bacteria
Live I-Bacteria I-Bacteria
Vaccine I-Bacteria I-Bacteria
Strain I-Bacteria I-Bacteria
( O I-Bacteria
LVS B-Bacteria I-Bacteria
) O O
and O O
promotes O O
LVS B-Bacteria O
binding O O
and O O
infection O O
of O O
human B-Habitat B-Habitat
monocyte B-Habitat I-Habitat
- I-Habitat I-Habitat
like I-Habitat I-Habitat
THP I-Habitat I-Habitat
- I-Habitat I-Habitat
1 I-Habitat I-Habitat
cells I-Habitat I-Habitat
. O O

The O O
HB O O
- O O
19 O O
pseudopeptide O O
that O O
binds O O
specifically O O
carboxy O O
- O O
terminal O O
RGG O O
domain O O
of O O
nucleolin O O
inhibits O O
LVS B-Bacteria O
binding O O
and O O
infection O O
of O O
monocyte B-Habitat O
- I-Habitat O
like I-Habitat O
THP I-Habitat B-Habitat
- I-Habitat I-Habitat
1 I-Habitat I-Habitat
cells I-Habitat I-Habitat
. O O

In O O
a O O
pull O O
- O O
down O O
assay O O
, O O
elongation O O
factor O O
Tu O O
( O O
EF O O
- O O
Tu O O
) O O
, O O
a O O
GTP O O
- O O
binding O O
protein O O
involved O O
in O O
protein O O
translation O O
, O O
usually O O
found O O
in O O
cytoplasm O O
, O O
was O O
recovered O O
among O O
LVS B-Bacteria O
bacterial O O
membrane O O
proteins O O
bound O O
on O O
RGG O O
domain O O
of O O
nucleolin O O
. O O

A O O
specific O O
polyclonal O O
murine B-Habitat O
antibody O O
was O O
raised O O
against O O
recombinant O O
LVS B-Bacteria O
EF O O
- O O
Tu O O
. O O

By O O
fluorescence O O
and O O
electron O O
microscopy O O
experiments O O
, O O
we O O
found O O
that O O
a O O
fraction O O
of O O
EF O O
- O O
Tu O O
could O O
be O O
detected O O
at O O
the O O
bacterial O O
surface O O
. O O

Anti O O
- O O
EF O O
- O O
Tu O O
antibodies O O
reduced O O
LVS B-Bacteria O
binding O O
to O O
monocyte B-Habitat O
- I-Habitat O
like I-Habitat O
THP I-Habitat B-Habitat
- I-Habitat I-Habitat
1 I-Habitat I-Habitat
cells I-Habitat I-Habitat
and O O
impaired O O
infection O O
, O O
even O O
in O O
absence O O
of O O
complement O O
and O O
complement O O
receptors O O
. O O

Interaction O O
between O O
EF O O
- O O
Tu O O
and O O
nucleolin O O
was O O
illustrated O O
by O O
two O O
different O O
pull O O
- O O
down O O
assays O O
using O O
recombinant O O
EF O O
- O O
Tu O O
proteins O O
and O O
either O O
RGG O O
domain O O
of O O
nucleolin O O
or O O
cell B-Habitat O
solubilized O O
nucleolin O O
. O O

Altogether O O
, O O
our O O
results O O
demonstrate O O
that O O
the O O
interaction O O
between O O
surface O O
nucleolin O O
and O O
its O O
bacterial O O
ligand O O
EF O O
- O O
Tu O O
plays O O
an O O
important O O
role O O
in O O
Francisella B-Bacteria B-Bacteria
tularensis I-Bacteria I-Bacteria
adhesion O O
and O O
entry O B-Habitat
process O O
and O O
may O O
therefore O O
facilitate O O
invasion O O
of O O
host B-Habitat O
tissues I-Habitat O
. O O

Since O O
phagosomal O O
escape O O
and O O
intra O O
- O O
cytosolic O O
multiplication O O
of O O
LVS B-Bacteria O
in O O
infected B-Habitat B-Habitat
monocytes I-Habitat I-Habitat
are O O
very O O
similar O O
to O O
those O O
of O O
human B-Habitat B-Habitat
pathogenic O O
F B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
tularensis I-Bacteria I-Bacteria
ssp I-Bacteria O
tularensis I-Bacteria O
, O O
the O O
mechanism O O
of O O
entry O O
into O O
monocyte B-Habitat O
- I-Habitat O
like I-Habitat O
THP I-Habitat B-Habitat
- I-Habitat I-Habitat
1 I-Habitat I-Habitat
cells I-Habitat I-Habitat
, O O
involving O O
interaction O O
between O O
EF O O
- O O
Tu O O
and O O
nucleolin O O
, O O
might O O
be O O
similar O O
in O O
the O O
two O O
subspecies O O
. O O

Thus O O
, O O
the O O
use O O
of O O
either O O
nucleolin O O
- O O
specific O O
pseudopeptide O O
HB O O
- O O
19 O O
or O O
recombinant O O
EF O O
- O O
Tu O O
could O O
provide O O
attractive O O
therapeutic O O
approaches O O
for O O
modulating O O
F B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
tularensis I-Bacteria I-Bacteria
infection O O
. O O

New O O
one O O
- O O
week O O
, O O
low O O
- O O
dose O O
triple O O
therapy O O
for O O
the O O
treatment O O
of O O
duodenal B-Habitat O
ulcer O O
with O O
Helicobacter B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
. O O

Antimicrobial O O
therapy O O
is O O
the O O
recommended O O
treatment O O
for O O
duodenal B-Habitat O
ulcer I-Habitat O
associated O O
with O O
Helicobacter B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
. O O

The O O
eradication O O
of O O
bismuth O B-Habitat
- O I-Habitat
based O I-Habitat
triple O I-Habitat
therapy O I-Habitat
with O I-Habitat
bismuth O I-Habitat
subcitrate O O
, O O
metronidazole O O
and O O
amoxicillin O O
is O O
limited O O
by O O
low O O
compliance O O
, O O
drug O O
resistance O O
and O O
side O O
- O O
effects O O
. O O

Two O O
- O O
week O O
proton O O
pump O O
inhibitor O O
( O O
PPI O O
) O O
- O O
based O O
triple O O
therapy O O
has O O
a O O
higher O O
eradication O O
rate O O
but O O
is O O
costly O O
. O O

This O O
study O O
was O O
designed O O
to O O
compare O O
the O O
efficacy O O
, O O
patient B-Habitat B-Habitat
compliance O O
and O O
cost O O
of O O
short O O
- O O
term O O
PPI O O
- O O
based O O
triple O O
therapy O O
with O O
those O O
of O O
bismuth O B-Habitat
- O I-Habitat
based O I-Habitat
triple O I-Habitat
therapy O I-Habitat
. O O

Ninety O B-Habitat
patients B-Habitat I-Habitat
with I-Habitat I-Habitat
active I-Habitat I-Habitat
duodenal I-Habitat I-Habitat
ulcer I-Habitat I-Habitat
disease I-Habitat O
and I-Habitat O
H I-Habitat B-Bacteria
pylori I-Habitat I-Bacteria
infection I-Habitat O
, O O
proven O O
with O O
the O O
13C O O
- O O
urea O O
breath O O
test O O
and O O
CLO O O
test O O
( O O
Campylobacter B-Bacteria B-Bacteria
- O O
like O O
organism O O
test O O
) O O
were O O
treated O O
randomly O O
in O O
three O O
therapeutic O O
groups O O
: O O
Group O B-Bacteria
A O I-Bacteria
, O O
DeNol O O
120 O O
mg O O
, O O
amoxicillin O O
500 O O
mg O O
and O O
metronidazole O O
250 O O
mg O O
four O O
times O O
a O O
day O O
orally O O
for O O
14 O O
days O O
; O O
Group O O
B O O
, O O
omeprazole O O
20 O O
mg O O
plus O O
clarithromycin O O
500 O O
mg O O
twice O O
a O O
day O O
and O O
amoxicillin O O
500 O O
mg O O
four O O
times O O
a O O
day O O
for O O
14 O O
days O O
; O O
Group O O
C O O
, O O
omeprazole O O
20 O O
mg O O
, O O
clarithromycin O O
250 O O
mg O O
and O O
metronidazole O O
500 O O
mg O O
twice O O
a O O
day O O
for O O
seven O O
days O O
. O O

Nizatidine O O
150 O O
mg O O
twice O O
a O O
day O O
was O O
given O O
continuously O O
following O O
the O O
end O O
of O O
anti O O
- O O
H B-Bacteria O
pylori I-Bacteria O
therapy O O
for O O
each O O
group O O
. O O

Two O O
months O O
later O O
, O O
endoscopy O O
, O O
the O O
CLO O O
test O O
and O O
13C O O
- O O
urea O O
breath O O
test O O
were O O
repeated O O
to O O
assess O O
the O O
eradication O O
rate O O
of O O
H B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
and O O
the O O
ulcer B-Habitat O
- O O
healing O O
rate O O
. O O

Drug O O
tolerance O O
was O O
evaluated O O
by O O
patients B-Habitat B-Habitat
themselves O O
by O O
daily O O
recording O O
of O O
any O O
side O O
- O O
effects O O
. O O

Eighty O O
- O O
four O O
patients B-Habitat B-Habitat
completed O O
the O O
entire O O
course O O
of O O
therapy O O
and O O
evaluation O O
for O O
H B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
. O O

The O O
H B-Bacteria O
pylori I-Bacteria O
eradication O O
rates O O
in O O
Groups O O
A O O
, O O
B O O
and O O
C O O
were O O
75 O O
% O O
( O O
21 O O
/ O O
28 O O
) O O
, O O
93 O O
% O O
( O O
26 O O
/ O O
28 O O
) O O
and O O
89 O O
% O O
( O O
25 O O
/ O O
28 O O
) O O
, O O
respectively O O
( O O
p O O
= O O
0 O O
. O O
466 O O
) O O
. O O

The O O
ulcer B-Habitat O
healing O O
rate O O
was O O
86 O O
% O O
( O O
24 O O
/ O O
28 O O
) O O
in O O
Group O O
A O O
and O O
89 O O
% O O
( O O
25 O O
/ O O
28 O O
) O O
in O O
Groups O O
B O O
and O O
C O O
( O O
p O O
= O O
0 O O
. O O
764 O O
) O O
. O O

A O O
total O O
of O O
74 O O
patients B-Habitat B-Habitat
( O O
88 O O
% O O
) O O
were O O
free O O
from O O
symptoms O O
at O O
the O O
end O O
of O O
the O O
triple O O
therapy O O
. O O

Symptom O O
relief O O
was O O
faster O O
in O O
patients B-Habitat B-Habitat
with I-Habitat I-Habitat
PPI I-Habitat I-Habitat
- I-Habitat I-Habitat
based I-Habitat I-Habitat
triple I-Habitat I-Habitat
therapy I-Habitat I-Habitat
( O O
Groups O O
B O O
and O O
C O O
) O O
( O O
days O O
3 O O
and O O
4 O O
) O O
than O O
for O O
patients B-Habitat B-Habitat
with I-Habitat I-Habitat
bismuth I-Habitat I-Habitat
- I-Habitat I-Habitat
based I-Habitat I-Habitat
triple I-Habitat I-Habitat
therapy I-Habitat I-Habitat
( O O
day O O
5 O O
) O O
. O O

The O O
cost O O
of O O
Group O B-Habitat
C O I-Habitat
therapy O I-Habitat
was O O
lower O O
than O O
that O O
for O O
Groups O O
A O O
and O O
B O O
. O O

There O O
were O O
no O O
major O O
side O O
- O O
effects O O
in O O
any O O
of O O
the O O
patients B-Habitat B-Habitat
. O O

One O O
- O O
week O O
triple O O
therapy O O
with O O
omeprazole O O
, O O
clarithromycin O O
and O O
metronidazole O O
is O O
highly O O
effected O O
for O O
the O O
eradication O O
of O O
H B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
. O O

A O O
therapeutic O O
regime O O
of O O
one O O
week O O
' O O
s O O
duration O O
with O O
lower O O
cost O O
, O O
good O O
compliance O O
and O O
mild O O
side O O
- O O
effects O O
may O O
offer O O
a O O
good O O
choice O O
for O O
treatment O O
of O O
duodenal B-Habitat O
ulcer I-Habitat O
associated O O
with O O
H B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
in O O
clinical O O
practice O O
. O O

Characterization O O
of O O
a O O
lipopolysaccharide O O
- O O
targeted O O
monoclonal O O
antibody O O
and O O
its O O
variable O O
fragments O O
as O O
candidates O O
for O O
prophylaxis O O
against O O
the O O
obligate O O
intracellular O O
bacterial O O
pathogen O O
Coxiella B-Bacteria B-Bacteria
burnetii I-Bacteria I-Bacteria
. O O

Our O O
previous O O
study O O
demonstrated O O
that O O
treatment O O
of O O
Coxiella B-Bacteria B-Bacteria
burnetii I-Bacteria I-Bacteria
with O O
the O O
phase O O
I O O
lipopolysaccharide O O
( O O
PI O O
- O O
LPS O O
) O O
- O O
targeted O O
monoclonal O O
antibody O O
( O O
MAb O O
) O O
1E4 O O
significantly O O
inhibited O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
infection O O
in O O
mice B-Habitat O
, O O
suggesting O O
that O O
1E4 O O
is O O
a O O
protective O O
MAb O O
. O O

To O O
determine O O
whether O O
passive O O
transfer O O
of O O
antibodies O O
( O O
Abs O O
) O O
can O O
provide O O
protection O O
against O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
natural O I-Bacteria
infection O O
, O O
we O O
examined O O
if O O
passive O O
transfer O O
of O O
1E4 O O
would O O
protect O O
SCID B-Habitat O
mice I-Habitat O
against O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
aerosol B-Habitat I-Bacteria
infection O O
. O O

The O O
results O O
indicated O O
that O O
1E4 O O
conferred O O
significant O O
protection O O
against O O
aerosolized B-Habitat O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
, O O
suggesting O O
that O O
1E4 O O
may O O
be O O
useful O O
for O O
preventing O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
natural O I-Bacteria
infection O O
. O O

To O O
further O O
understand O O
the O O
mechanisms O O
of O O
1E4 O O
- O O
mediated O O
protection O O
and O O
to O O
test O O
the O O
possibility O O
of O O
using O O
humanized O O
1E4 O O
to O O
prevent O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
infection O O
, O O
we O O
examined O O
whether O O
the O O
Fab O O
fragment O O
of O O
1E4 O O
( O O
Fab1E4 O O
) O O
, O O
a O O
recombinant O O
murine B-Habitat O
single O O
- O O
chain O O
variable O O
fragment O O
( O O
muscFv1E4 O O
) O O
, O O
and O O
a O O
humanized O O
single O O
- O O
chain O O
variable O O
fragment O O
( O O
huscFv1E4 O O
) O O
retained O O
the O O
ability O O
of O O
1E4 O O
to O O
inhibit O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
infection O O
. O O

The O O
results O O
indicated O O
that O O
Fab1E4 O O
, O O
muscFv1E4 O O
, O O
and O O
huscFv1E4 O O
were O O
able O O
to O O
inhibit O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
infection O O
in O O
mice B-Habitat O
but O O
that O O
their O O
ability O O
to O O
inhibit O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
infection O O
was O O
lower O O
than O O
that O O
of O O
1E4 O O
. O O

In O O
addition O O
, O O
treatment O O
of O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
with O O
Fab1E4 O O
, O O
muscFv1E4 O O
, O O
or O O
huscFv1E4 O O
can O O
block O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
infection O O
of O O
macrophages B-Habitat O
. O O

Interestingly O O
, O O
treatment O O
of O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
with O O
huscFv1E4 O O
can O O
significantly O O
reduce O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
infectivity O O
in O O
human B-Habitat B-Habitat
macrophages I-Habitat I-Habitat
. O O

This O O
report O O
provides O O
the O O
first O O
evidence O O
to O O
demonstrate O O
that O O
the O O
humanized O O
variable O O
fragments O O
of O O
an O O
LPS O O
- O O
specific O O
MAb O O
can O O
neutralize O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
infection O O
and O O
appears O O
to O O
be O O
a O O
promising O O
step O O
toward O O
the O O
potential O O
use O O
of O O
a O O
humanized O O
MAb O O
as O O
emergency O O
prophylaxis O O
against O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
burnetii I-Bacteria I-Bacteria
exposure O O
. O O

Cloning O O
, O O
expression O O
, O O
purification O O
, O O
crystallization O O
and O O
X O O
- O O
ray O O
crystallographic O O
analysis O O
of O O
Rv3168 O O
from O O
Mycobacterium B-Bacteria B-Bacteria
tuberculosis I-Bacteria I-Bacteria
H37Rv I-Bacteria O
. O O

Tuberculosis O O
is O O
a O O
widespread O O
and O O
deadly O O
infectious O O
disease O O
, O O
with O O
one O O
third O O
of O O
the O O
human B-Habitat B-Habitat
population I-Habitat O
already O O
being O O
infected O O
. O O

Aminoglycoside O O
antibiotics O O
have O O
become O O
less O O
effective O O
in O O
recent O O
years O O
owing O O
to O O
antibiotic O O
resistance O O
, O O
which O O
arises O O
primarily O O
through O O
enzymatic O O
modification O O
of O O
the O O
antibiotics O O
. O O

The O O
gene O O
product O O
Rv3168 O O
, O O
a O O
putative O O
aminoglycoside O O
phosphotransferase O O
( O O
APH O O
) O O
, O O
from O O
Mycobacterium B-Bacteria B-Bacteria
tuberculosis I-Bacteria I-Bacteria
was O O
crystallized O O
using O O
the O O
sitting O O
- O O
drop O O
vapour O O
- O O
diffusion O O
method O O
in O O
the O O
presence O O
of O O
0 O O
. O O
2 O O
M O O
calcium O O
acetate O O
, O O
0 O O
. O O
1 O O
M O O
Tris O O
- O O
HCl O O
pH O O
7 O O
. O O
0 O O
and O O
20 O O
% O O
PEG O O
3000 O O
at O O
295 O O
K O B-Bacteria
. O I-Bacteria
X O I-Bacteria
- O O
ray O O
diffraction O O
data O O
were O O
collected O O
to O O
a O O
maximum O O
resolution O O
of O O
1 O O
. O O
67 O O
Å O O
on O O
a O O
synchrotron O O
beamline O O
. O O

The O O
crystal O O
belonged O O
to O O
space O O
group O O
P2 O O
( O O
1 O O
) O O
2 O O
( O O
1 O O
) O O
2 O O
( O O
1 O O
) O O
, O O
with O O
unit O O
- O O
cell O O
parameters O O
a O O
= O O
56 O O
. O O
74 O O
, O O
b O O
= O O
62 O O
. O O
37 O O
, O O
c O O
= O O
103 O O
. O O
61 O O
Å O O
. O O

With O O
one O O
molecule O O
per O O
asymmetric O O
unit O O
, O O
the O O
crystal O O
volume O O
per O O
unit O O
protein O O
weight O O
( O O
V O O
( O O
M O O
) O O
) O O
is O O
2 O O
. O O
91 O O
Å O O
( O O
3 O O
) O O
Da O O
( O O
- O O
1 O O
) O O
. O O

The O O
structure O O
was O O
solved O O
by O O
the O O
single O O
- O O
wavelength O O
anomalous O O
dispersion O O
method O O
and O O
refinement O O
of O O
the O O
selenomethionine O O
structure O O
is O O
in O O
progress O O
. O O

Methods O O
for O O
the O O
detection O O
of O O
a O O
specific O O
Mycobacterium B-Bacteria B-Bacteria
leprae I-Bacteria I-Bacteria
antigen O O
in O O
the O O
urine B-Habitat O
of I-Habitat O
leprosy I-Habitat B-Habitat
patients I-Habitat I-Habitat
. O O

Two O O
methods O O
for O O
detecting O O
the O O
phenolic O O
glycolipid O O
, O O
PGL O O
- O O
1 O O
, O O
a O O
Mycobacterium B-Bacteria B-Bacteria
leprae I-Bacteria I-Bacteria
- O O
specific O O
molecule O O
, O O
in O O
the O O
urine B-Habitat O
of I-Habitat O
leprosy I-Habitat B-Habitat
patients I-Habitat I-Habitat
are O O
described O O
. O O

Both O O
methods O O
rely O O
on O O
the O O
100 O O
- O O
fold O O
preconcentration O O
of O O
the O O
urine B-Habitat O
, O O
which O O
can O O
be O O
accomplished O O
by O O
a O O
single O O
- O O
step O O
ultrafiltration O O
procedure O O
. O O

The O O
equivalent O O
of O O
approximately O O
2 O O
. O O
5 O O
micrograms O O
of O O
PGL O O
- O O
1 O O
/ O O
ml O O
was O O
detected O O
in O O
the O O
urine B-Habitat B-Habitat
of I-Habitat I-Habitat
LL I-Habitat I-Habitat
patients I-Habitat I-Habitat
with O I-Habitat
an O I-Habitat
inhibition O O
ELISA O O
. O O

The O O
second O O
method O O
, O O
a O O
direct O O
dot O O
- O O
blot O O
assay O O
on O O
nitrocellulose B-Habitat O
paper I-Habitat O
, O O
was O O
much O O
simpler O O
and O O
more O O
sensitive O O
. O O

As O O
little O O
as O O
3 O O
ng O O
of O O
antigen O O
was O O
detected O O
by O O
the O O
dot O O
- O O
blot O O
technique O O
. O O

PGL O O
- O O
1 O O
was O O
detected O O
in O O
the O O
urine B-Habitat B-Habitat
of I-Habitat I-Habitat
LL I-Habitat I-Habitat
patients I-Habitat I-Habitat
. O O

A O O
general O O
strategy O O
for O O
the O O
bacterial O O
expression O O
of O O
amyloidogenic O O
peptides O O
using O O
BCL O O
- O O
XL O O
- O O
1 O O
/ O O
2 O O
fusions O O
. O O

Biophysical O O
studies O O
on O O
amyloidogenic O O
and O O
aggregation O O
- O O
prone O O
peptides O O
often O O
require O O
large O O
quantities O O
of O O
material O O
. O O

However O O
, O O
solid O O
- O O
phase O O
synthesis O O
, O O
handling O O
, O O
and O O
purification O O
of O O
peptides O O
often O O
present O O
challenges O O
on O O
these O O
scales O O
. O O

Recombinant O O
expression O O
is O O
an O O
attractive O O
alternative O O
because O O
of O O
its O O
low O O
cost O O
, O O
the O O
ability O O
to O O
isotopically O O
label O O
the O O
peptides O O
, O O
and O O
access O O
to O O
sequences O O
exceeding O O
approximately O O
50 O O
residues O O
. O O

However O O
, O O
expression O O
systems O O
that O O
seek O O
to O O
solubilize O O
amyloidogenic O O
peptides O O
suffer O O
from O O
low O B-Habitat
yields O I-Habitat
, O O
difficult O O
optimizations O O
, O O
and O O
isolation O O
challenges O O
. O O

We O O
present O O
a O O
general O O
strategy O O
for O O
expressing O O
and O O
isolating O O
amyloidogenic O O
peptides O O
in O O
Escherichia B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
by O O
fusion O O
to O O
a O O
polypeptide O O
that O O
drives O O
the O O
expression O O
of O O
attached O O
peptides O O
into O O
bacterial O O
inclusion O O
bodies O O
. O O

This O O
scheme O O
minimizes O O
toxicity O O
during O O
bacterial O O
growth O O
and O O
enables O O
the O O
processing O O
and O O
handling O O
of O O
the O O
peptides O O
in O O
denaturing O O
solutions O O
. O O

Immobilized O O
metal O O
affinity O O
chromatography O O
, O O
reverse O O
phase O O
HPLC O O
, O O
and O O
cyanogen O O
bromide O O
cleavage O O
are O O
used O O
to O O
isolate O O
the O O
peptide O O
, O O
followed O O
by O O
further O O
reverse O O
phase O O
HPLC O O
, O O
which O O
yields O O
milligram O O
quantities O O
of O O
the O O
purified O O
peptide O O
. O O

We O O
demonstrate O O
that O O
driving O O
the O O
peptides O O
into O O
inclusion O O
bodies O O
using O O
fusion O O
to O O
BCL O O
- O O
XL O O
- O O
1 O O
/ O O
2 O O
is O O
a O O
general O O
strategy O O
for O O
their O O
expression O O
and O O
isolation O O
, O O
as O O
exemplified O O
by O O
the O O
production O O
of O O
11 O O
peptides O O
species O O
. O O

Clonal O O
strains O O
of O O
Pseudomonas B-Bacteria B-Bacteria
aeruginosa I-Bacteria I-Bacteria
in O O
paediatric B-Habitat B-Habitat
and O I-Habitat
adult B-Habitat I-Habitat
cystic O I-Habitat
fibrosis O I-Habitat
units O I-Habitat
. O O

Despite O O
recent O O
reports O O
of O O
clonal O O
strains O O
of O O
Pseudomonas B-Bacteria B-Bacteria
aeruginosa I-Bacteria I-Bacteria
in O O
cystic B-Habitat O
fibrosis I-Habitat O
( I-Habitat O
CF I-Habitat O
) I-Habitat O
units I-Habitat O
, O O
the O O
need O O
for O O
routine O O
microbiological O O
surveillance O O
remains O O
contentious O O
. O O

Sputum B-Habitat O
was O O
collected O O
prospectively O O
from O O
productive B-Habitat O
patients I-Habitat B-Habitat
attending O O
the O O
regional O O
paediatric B-Habitat O
and O O
adult B-Habitat O
CF O O
units O O
in O O
Brisbane O O
, O O
Australia O O
. O O

All O O
P B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
aeruginosa I-Bacteria I-Bacteria
isolates O O
were O O
typed O O
using O O
pulsed O O
- O O
field O O
gel O O
electrophoresis O O
. O O

Spirometry O O
, O O
anthropometrics O O
, O O
hospitalisations O O
and O O
antibiotic O O
sensitivity O O
data O O
were O O
recorded O O
. O O

The O O
first O O
100 O O
sputum B-Habitat B-Habitat
samples O I-Habitat
( O O
first O O
50 O O
patients B-Habitat B-Habitat
at O I-Habitat
each O I-Habitat
clinic B-Habitat I-Habitat
) O O
harboured O O
163 O O
isolates O O
of O O
P B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
aeruginosa I-Bacteria I-Bacteria
. O O

A O O
total O O
of O O
39 O O
patients B-Habitat B-Habitat
shared O O
a O O
common O O
strain O O
( O O
pulsotype O O
2 O O
) O O
, O O
20 O O
patients B-Habitat B-Habitat
shared O O
a O O
strain O O
with O O
at O O
least O O
one O O
other O O
patient B-Habitat O
and O O
41 O O
patients B-Habitat B-Habitat
harboured O O
unique O O
strains O O
. O O

Eight O O
patients B-Habitat B-Habitat
shared O O
a O O
strain O O
identical O O
to O O
a O O
previously O O
reported O O
Australian O O
transmissible O O
strain O O
( O O
pulsotype O O
1 O O
) O O
. O O

Compared O O
with O O
the O O
unique O O
strain O O
group O O
, O O
patients B-Habitat B-Habitat
harbouring O O
pulsotype O O
2 O O
were O O
younger O O
and O O
had O O
poorer O O
lung B-Habitat O
function O O
. O O

Treatment O O
requirements O O
were O O
similar O O
in O O
these O O
two O O
groups O O
, O O
as O O
were O O
the O O
rates O O
of O O
multiresistance O O
. O O

In O O
conclusion O O
, O O
59 O O
% O O
of O O
patients B-Habitat B-Habitat
harboured O O
a O O
clonal O O
strain O O
, O O
supporting O O
the O O
need O O
for O O
routine O O
microbiological O O
surveillance O O
. O O

In O O
contrast O O
to O O
previously O O
described O O
clonal O O
strains O O
, O O
the O O
dominant O O
pulsotype O O
was O O
indistinguishable O O
from O O
nonclonal O O
strains O O
with O O
respect O O
to O O
both O O
colonial O O
morphology O O
and O O
multiresistance O O
. O O

The O O
clinical O O
significance O O
of O O
clonal O O
strains O O
remains O O
uncertain O O
and O O
requires O O
longitudinal O O
study O O
. O O

Association O O
of O O
mutation O O
patterns O O
in O O
GyrA O O
and O O
ParC O O
genes O O
with O O
quinolone O O
resistance O O
levels O O
in O O
lactic B-Bacteria O
acid I-Bacteria O
bacteria I-Bacteria O
. O O

The O O
quinolone O O
resistance O O
of O O
19 O O
lactic B-Bacteria O
acid I-Bacteria O
bacterial I-Bacteria O
strains O O
belonging O O
to O O
the O O
genera O O
Enterococcus B-Bacteria B-Bacteria
and O O
Lactobacillus B-Bacteria O
isolated O O
from O O
the O O
natural B-Habitat B-Habitat
fermented I-Habitat I-Habitat
koumiss I-Habitat I-Habitat
and O I-Habitat
yoghurt B-Habitat I-Habitat
were O O
investigated O O
. O O

The O O
objective O O
of O O
this O O
study O O
was O O
to O O
determine O O
the O O
quinolone O O
resistance O O
levels O O
and O O
to O O
explore O O
the O O
association O O
of O O
the O O
resistance O O
with O O
the O O
mutation O O
patterns O O
in O O
gyrA O O
and O O
parC O O
genes O O
, O O
as O O
is O O
currently O O
recommended O O
by O O
the O O
Food O O
and O O
Agriculture O O
Organization O O
/ O O
World O O
Health O O
Organization O O
Joint O O
Expert O O
Committee O O
in O O
Guidelines O O
for O O
Evaluation O O
of O O
Probiotics O O
in O O
Food O O
for O O
probiotic O O
lactic B-Bacteria O
acid I-Bacteria O
bacteria I-Bacteria O
drug O O
resistance O O
in O O
2001 O O
. O O

The O O
Oxford O O
Cup O O
method O O
and O O
double O O
- O O
tube O O
dilution O O
method O O
were O O
used O O
to O O
determine O O
the O O
quinolone O O
resistance O O
levels O O
of O O
the O O
isolated O O
strains O O
. O O

Generally O O
, O O
all O O
of O O
the O O
19 O O
strains O O
showed O O
resistance O O
towards O O
norfloxacin O O
and O O
ciprofloxacin O O
when O O
the O O
Oxford O O
cup O O
method O O
was O O
used O O
, O O
whereas O O
the O O
incidence O O
was O O
lower O O
( O O
to O O
norfloxacin O O
89 O O
. O O
5 O O
% O O
and O O
to O O
ciprofloxacin O O
68 O O
. O O
4 O O
% O O
) O O
when O O
minimum O O
inhibitory O O
concentration O O
breakpoints O O
( O O
CLSI O O
M100 O O
- O O
S23 O O
) O O
were O O
tested O O
. O O

Furthermore O O
, O O
gene O O
sequencing O O
was O O
conducted O O
on O O
gyrA O O
and O O
parC O O
of O O
topoisomerase O O
II O O
of O O
these O O
isolated O O
strains O O
. O O

The O O
genetic O O
basis O O
for O O
quinolone O O
resistance O O
may O O
be O O
closely O O
related O O
to O O
mutations O O
in O O
gyrA O O
genes O O
as O O
there O O
were O O
10 O O
mutation O O
sites O O
in O O
amino O O
- O O
acid O O
sequences O O
encoded O O
by O O
gyrA O O
genes O O
in O O
10 O O
quinolone O O
resistance O O
strains O O
and O O
14 O O
mutation O O
sites O O
in O O
Enterococcus B-Bacteria B-Bacteria
durans I-Bacteria I-Bacteria
HZ28 I-Bacteria I-Bacteria
, O O
whereas O O
no O O
typical O O
mutations O O
were O O
detected O O
in O O
parC O O
genes O O
. O O

Construction O O
of O O
a O O
cloning O O
vector O O
from O O
a O O
naturally O O
occurring O O
plasmid O O
of O O
Salmonella B-Bacteria B-Bacteria
typhimurium I-Bacteria I-Bacteria
. O O

A O O
naturally O O
occurring O O
plasmid O O
isolated O O
from O O
a O O
drug O O
- O O
resistant O O
strain O O
of O O
Salmonella B-Bacteria B-Bacteria
typhimurium I-Bacteria I-Bacteria
( I-Bacteria O
993 I-Bacteria O
) I-Bacteria O
has O O
been O O
used O O
to O O
construct O O
a O O
plasmid O O
vector O O
for O O
cloning O O
in O O
a O O
wild O O
strain O O
of O O
Salmonella B-Bacteria B-Bacteria
. O O

The O O
strain O O
( B-Bacteria O
993 I-Bacteria O
) I-Bacteria O
contains O O
at O O
least O O
two O O
plasmids O O
. O O

The O O
smaller O O
plasmid O O
( O O
9 O O
kb O O
) O O
contains O O
an O O
ampicillin O O
- O O
resistant O O
marker O O
, O O
while O O
the O O
larger O O
one O O
( O O
25 O O
kb O O
) O O
is O O
cryptic O O
. O O

Physical O O
mapping O O
of O O
the O O
9 O O
- O O
kb O O
plasmid O O
and O O
construction O O
of O O
a O O
3 O O
. O O
5 O O
- O O
kb O O
derivative O O
have O O
been O O
carried O O
out O O
. O O

This O O
plasmid O O
has O O
been O O
used O O
for O O
cloning O O
in O O
a O O
restriction O O
+ O O
modification O O
+ O O
strain O O
of O O
S B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
typhimurium I-Bacteria I-Bacteria
using O O
a O O
conventional O B-Habitat
calcium O I-Habitat
chloride O I-Habitat
method O I-Habitat
. O O

It O O
exhibited O O
better O O
efficiency O O
of O O
transformation O O
than O O
other O O
commonly O O
used O O
plasmids O O
such O O
as O O
pBR322 O O
or O O
its O O
derivatives O O
and O O
transformants O O
were O O
found O O
to O O
be O O
stable O O
in O O
the O O
absence O O
of O O
antibiotic O O
selection O O
. O O

The O O
vector O O
is O O
compatible O O
with O O
pBR322 O O
and O O
can O O
be O O
used O O
to O O
study O O
the O O
expression O O
of O O
cloned O O
genes O O
in O O
minicells O B-Habitat
. O O

Lipopolysaccharide O O
from O O
nonvirulent O O
Ara B-Bacteria O
+ I-Bacteria O
Burkholderia I-Bacteria B-Bacteria
pseudomallei I-Bacteria I-Bacteria
isolates O O
is O O
immunologically O O
indistinguishable O O
from O O
lipopolysaccharide O O
from O O
virulent O O
Ara B-Bacteria O
- I-Bacteria O
clinical B-Habitat O
isolates O O
. O O

Different O O
lines O O
of O O
evidence O O
suggest O O
that O O
a O O
discrepancy O O
between O O
the O O
distribution O O
of O O
Burkholderia O B-Bacteria
( O O
Pseudomonas O B-Bacteria
) O O
pseudomallei O O
in O O
the O O
environment O O
and O O
the O O
distribution O O
of O O
the O O
disease O O
melioidosis O O
is O O
attributable O O
, O O
at O O
least O O
in O O
part O O
, O O
to O O
phenotypic O O
differences O O
between O O
clinical B-Habitat O
and O O
some O O
environmental O O
isolates O O
. O O

Two O O
antigenically O O
and O O
biochemically O O
distinct O O
biotypes O O
have O O
been O O
described O O
, O O
only O O
one O O
of O O
which O O
is O O
virulent O O
. O O

In O O
this O O
study O O
, O O
lipopolysaccharides O O
( O O
LPSs O O
) O O
were O O
extracted O O
by O O
the O O
proteinase O O
K O O
digestion O O
method O O
from O O
a O O
total O O
of O O
214 O O
B B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pseudomallei I-Bacteria I-Bacteria
isolates O O
, O O
and O O
their O O
immunoreactivities O O
with O O
sera B-Habitat O
from I-Habitat O
patients I-Habitat B-Habitat
with I-Habitat I-Habitat
different I-Habitat I-Habitat
clinical I-Habitat I-Habitat
spectra I-Habitat O
and I-Habitat O
with I-Habitat O
other I-Habitat O
infections I-Habitat O
were O O
evaluated O O
. O O

With O O
the O O
exception O O
of4 O O
isolates O O
from O O
a O O
total O O
of O O
214 O O
tested O O
, O O
the O O
sodium O O
dodecyl O O
sulfate O O
- O O
polyacrylamide O O
gel O O
electrophoresis O O
silver O O
- O O
staining O O
profiles O O
of O O
the O O
LPSs O O
from O O
the O O
two O O
biotypes O O
showed O O
identical O O
ladder O O
patterns O O
that O O
were O O
typical O O
for O O
smooth O O
LPSs O O
from O O
other O O
gram O O
- O O
negative O O
bacteria O O
. O O

The O O
210 O O
isolates O O
with O O
typical O O
LPS O O
patterns O O
( O O
119 O O
Ara B-Bacteria O
- I-Bacteria O
clinical B-Habitat O
, O O
13 O O
Ara B-Bacteria B-Habitat
- I-Bacteria I-Habitat
soil B-Habitat I-Habitat
, O O
70 O O
Ara B-Bacteria B-Bacteria
+ I-Bacteria I-Bacteria
soil B-Habitat I-Bacteria
, O O
and O O
8 O O
reference O O
National O O
Type O O
Culture O O
Collection O O
strains O O
) O O
also O O
exhibited O O
similar O O
immunoblot O O
profiles O O
against O O
pooled O O
sera B-Habitat O
from I-Habitat O
patients I-Habitat B-Habitat
with I-Habitat I-Habitat
melioidosis I-Habitat I-Habitat
and O I-Habitat
hyperimmune B-Habitat I-Habitat
mouse I-Habitat I-Habitat
sera I-Habitat I-Habitat
. O O

Concordant O O
findings O O
were O O
noted O O
in O O
the O O
indirect O O
enzyme O O
- O O
linked O O
immunosorbent O O
assay O O
with O O
Ara B-Bacteria O
- I-Bacteria O
and O O
Ara B-Bacteria O
+ I-Bacteria O
LPSs O O
to O O
coat O O
the O O
microtiter O O
plates O O
. O O

The O O
LPSs O O
of O O
the O O
different O O
B B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pseudomallei I-Bacteria I-Bacteria
biotypes O O
appear O O
antigenically O O
indistinguishable O O
. O O

It O O
is O O
, O O
therefore O O
, O O
unlikely O O
that O O
this O O
component O O
is O O
related O O
to O O
the O O
virulence O O
and O O
pathogenicity O O
of O O
B B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pseudomallei I-Bacteria I-Bacteria
. O O

Human B-Habitat O
and O O
tick B-Habitat O
spotted B-Bacteria O
fever I-Bacteria O
group I-Bacteria O
Rickettsia B-Bacteria O
isolates O O
from O O
Israel O O
: O O
a O O
genotypic O O
analysis O O
. O O

The O O
genomes O O
of O O
spotted B-Bacteria O
fever I-Bacteria O
group I-Bacteria O
rickettsiae B-Bacteria O
isolated O O
in O O
different O O
geographical O O
areas O O
of O O
Israel O O
( O O
two O O
from O O
ticks B-Habitat O
and O O
four O O
from O O
humans B-Habitat B-Habitat
, O O
obtained O O
over O O
a O O
span O O
of O O
20 O O
years O O
) O O
were O O
studied O O
by O O
polymerase O O
chain O O
reaction O O
( O O
PCR O O
) O O
and O O
restriction O O
endonuclease O O
fragment O O
length O O
polymorphism O O
( O O
RFLP O O
) O O
analysis O O
. O O

The O O
human B-Habitat B-Habitat
isolates O O
were O O
obtained O O
from O O
patients B-Habitat B-Habitat
suffering I-Habitat O
from I-Habitat O
rickettsial I-Habitat O
disease I-Habitat O
of I-Habitat O
different I-Habitat O
degrees I-Habitat O
of I-Habitat O
severity I-Habitat O
. O O

The O O
PCR O O
products O O
obtained O O
with O O
five O O
pairs O O
of O O
oligonucleotide O O
primers O O
( O O
two O O
primer O O
sets O O
derived O O
from O O
the O O
190 O O
- O O
kDa O O
polypeptide O O
gene O O
and O O
three O O
from O O
the O O
120 O O
- O O
kDa O O
polypeptide O O
gene O O
) O O
and O O
cleaved O O
with O O
restriction O O
endonucleases O O
were O O
used O O
to O O
study O O
the O O
Israeli O O
isolates O O
and O O
reference O O
Rickettsia B-Bacteria O
conorii I-Bacteria O
isolates O O
. O O

Subtle O O
differences O O
between O O
the O O
PCR O O
- O O
RFLP O O
patterns O O
of O O
Israeli O O
isolates O O
and O O
the O O
two O O
R O B-Bacteria
. O I-Bacteria
conorii O I-Bacteria
reference O O
strains O O
( O O
Moroccan O O
and O O
no O O
. O O

7 O O
) O O
were O O
seen O O
when O O
the O O
PCR O O
products O O
derived O O
from O O
the O O
190 O O
- O O
kDa O O
gene O O
- O O
derived O O
primer O O
sets O O
were O O
digested O O
. O O

All O O
of O O
the O O
Israeli O O
isolates O O
were O O
identical O O
by O O
RFLP O O
analysis O O
using O O
all O O
of O O
the O O
primer O O
sets O O
. O O

This O O
study O O
showed O O
that O O
the O O
Israeli O O
spotted B-Bacteria O
fever I-Bacteria O
group I-Bacteria O
isolates O O
( O O
from O O
both O O
ticks B-Habitat O
and O O
humans B-Habitat B-Habitat
) O O
were O O
genetically O O
homogeneous O O
by O O
the O O
criteria O O
used O O
in O O
this O O
study O O
, O O
despite O O
the O O
time O O
and O O
location O O
differences O O
in O O
their O O
original O O
isolation O O
, O O
and O O
different O O
as O O
a O O
group O O
from O O
R B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
conorii I-Bacteria I-Bacteria
. O O

Characterization O O
of O O
a O O
mosquitocidal O O
Bacillus B-Bacteria B-Bacteria
thuringiensis I-Bacteria I-Bacteria
serovar I-Bacteria O
sotto I-Bacteria O
strain O O
isolated O O
from O O
Okinawa O O
, O O
Japan O O
. O O

To O O
characterize O O
the O O
mosquitocidal O O
activity O O
of O O
parasporal O O
inclusions O O
of O O
the O O
Bacillus B-Bacteria B-Bacteria
thuringiensis I-Bacteria I-Bacteria
serovar I-Bacteria O
sotto I-Bacteria O
strain I-Bacteria O
96 I-Bacteria O
- I-Bacteria O
OK I-Bacteria O
- I-Bacteria O
85 I-Bacteria O
- I-Bacteria O
24 I-Bacteria O
, O O
for O O
comparison O O
with O O
two O O
well O O
- O O
characterized O O
mosquitocidal O O
strains O O
. O O

The O O
strain O O
96 B-Bacteria O
- I-Bacteria O
OK I-Bacteria O
- I-Bacteria O
85 I-Bacteria O
- I-Bacteria O
24 I-Bacteria O
significantly O O
differed O O
from O O
the O O
existing O O
mosquitocidal O O
B B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
thuringiensis I-Bacteria I-Bacteria
strains O O
in O O
: O O
( O O
1 O O
) O O
lacking O O
the O O
larvicidal O O
activity O O
against O O
Culex B-Habitat O
pipiens I-Habitat O
molestus I-Habitat O
and O O
haemolytic O O
activity O O
, O O
and O O
( O O
2 O O
) O O
SDS O O
- O O
PAGE O O
profiles O O
, O O
immunological O O
properties O O
and O O
N O O
- O O
terminal O O
amino O O
acid O O
sequences O O
of O O
parasporal O O
inclusion O O
proteins O O
. O O

It O O
is O O
clear O O
from O O
the O O
results O O
that O O
the O O
strain O O
96 B-Bacteria O
- I-Bacteria O
OK I-Bacteria O
- I-Bacteria O
85 I-Bacteria O
- I-Bacteria O
24 I-Bacteria O
synthesizes O O
a O O
novel O O
mosquitocidal O O
Cry O O
protein O O
with O O
a O O
unique O O
toxicity O O
spectrum O O
. O O

This O O
is O O
the O O
first O O
report O O
of O O
the O O
occurrence O O
of O O
a O O
mosquitocidal O O
B B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
thuringiensis I-Bacteria I-Bacteria
strain O O
with O O
an O O
unusual O O
toxicity O O
spectrum O O
, O O
lacking O O
the O O
activity O O
against O O
the O O
culicine B-Habitat O
mosquito I-Habitat O
. O O

Evaluation O O
of O O
two O O
commercial O O
methods O O
for O O
the O O
detection O O
of O O
Listeria B-Bacteria B-Bacteria
sp I-Bacteria I-Bacteria
. I-Bacteria O

and O O
Listeria B-Bacteria B-Bacteria
monocytogenes I-Bacteria I-Bacteria
in O O
a O O
chicken B-Habitat B-Habitat
nugget I-Habitat I-Habitat
processing I-Habitat I-Habitat
plant I-Habitat I-Habitat
. O O

This O O
study O O
measures O O
the O O
detection O O
performances O O
of O O
two O O
rapid O O
test O O
systems O O
( O O
Listeria O O
Rapid O O
Test O O
Clearview O O
and O O
Bax O O
system O O
) O O
for O O
the O O
screening O O
of O O
Listeria B-Bacteria B-Bacteria
sp I-Bacteria I-Bacteria
. I-Bacteria O

and O O
Listeria B-Bacteria B-Bacteria
monocytogenes I-Bacteria I-Bacteria
, O O
respectively O O
. O O

A O O
total O O
of O O
413 O O
samples O O
from O O
different O O
sources O O
( O O
product O O
from O O
( O O
i O O
) O O
different O O
stages O O
of O O
processing O O
, O O
( O O
ii O O
) O O
different O O
environments O O
, O O
and O O
( O O
iii O O
) O O
different O O
food B-Habitat O
handlers O O
) O O
, O O
collected O O
from O O
a O O
chicken B-Habitat B-Habitat
nugget I-Habitat I-Habitat
processing I-Habitat I-Habitat
plant I-Habitat I-Habitat
, O O
were O O
analysed O O
by O O
both O O
rapid O O
methods O O
and O O
a O O
cultural O O
method O O
consisting O O
of O O
pre O O
- O O
enrichment O O
, O O
enrichment O O
, O O
and O O
isolation O O
onto O O
selective B-Habitat O
agars I-Habitat O
( O O
PALCAM B-Habitat O
, O O
LPM B-Habitat O
, O O
and O O
HCLA B-Habitat O
) O O
. O O

Overall O O
, O O
results O O
showed O O
an O O
excellent O O
correlation O O
between O O
data O O
obtained O O
using O O
Clearview O O
and O O
the O O
cultural O O
method O O
, O O
with O O
Clearview O O
presenting O O
an O O
efficiency O O
of O O
99 O O
% O O
. O O

Bax O O
showed O O
a O O
lower O O
correlation O O
using O O
the O O
cultural O O
method O O
, O O
with O O
an O O
efficiency O O
of O O
71 O O
. O O
1 O O
% O O
. O O

The O O
type O O
of O O
sample O O
did O O
not O O
affect O O
the O O
efficiency O O
of O O
Clearview O O
, O O
which O O
varied O O
from O O
98 O O
. O O
1 O O
% O O
for O O
product B-Habitat O
samples I-Habitat O
to O O
100 O O
% O O
for O O
environmental O O
and O O
food B-Habitat B-Habitat
handler I-Habitat I-Habitat
samples O I-Habitat
, O O
while O O
for O O
Bax O O
it O O
had O O
a O O
marked O O
influence O O
. O O

Efficiency O O
of O O
Bax O O
varied O O
from O O
as O O
high O O
as O O
100 O O
% O O
for O O
food B-Habitat B-Habitat
handlers O I-Habitat
to O O
37 O O
. O O
9 O O
% O O
for O O
product B-Habitat O
samples I-Habitat O
. O O

Long O O
- O O
term O O
Helicobacter B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
and O O
the O O
development O O
of O O
atrophic O O
gastritis O O
and O O
gastric B-Habitat B-Habitat
cancer O O
in O O
Japan O O
. O O

The O O
incidence O O
of O O
gastric B-Habitat B-Habitat
cancer O I-Habitat
and O O
the O O
prevalence O O
of O O
Helicobacter B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
are O O
high O O
in O O
Japan O O
, O O
so O O
it O O
is O O
an O O
important O O
issue O O
whether O O
long O O
- O O
term O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
leads O O
to O O
chronic O O
atrophic O O
gastritis O O
, O O
considered O O
one O O
of O O
the O O
precursors O O
of O O
gastric B-Habitat B-Habitat
cancer O I-Habitat
. O O

We O O
have O O
reported O O
that O O
the O O
grade O O
of O O
atrophy O O
was O O
higher O O
in O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
- O O
positive O O
subjects O O
than O O
in O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
- O O
negative O O
subjects O O
. O O

It O O
has O O
also O O
been O O
reported O O
that O O
the O O
atrophy O O
of O O
gastric B-Habitat B-Habitat
mucosa O I-Habitat
increased O O
in O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
- O O
infected O O
monkeys O O
compared O O
with O O
control B-Habitat O
monkeys I-Habitat O
in O O
a O O
5 O O
- O O
year O O
follow O O
- O O
up O O
study O O
. O O

Most O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
infections O O
occur O O
in O O
children B-Habitat B-Habitat
, O O
and O O
atrophy O O
of O O
the O O
gastric B-Habitat B-Habitat
mucosa I-Habitat O
progresses O O
during O O
aging O O
. O O

Long O O
- O O
term O O
data O O
show O O
that O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
can O O
lead O O
to O O
gastric B-Habitat B-Habitat
atrophy O O
and O O
may O O
play O O
an O O
important O O
role O O
in O O
the O O
development O O
of O O
gastric B-Habitat B-Habitat
cancer O I-Habitat
. O O

Interestingly O O
, O O
there O O
was O O
no O O
difference O O
in O O
the O O
prevalence O O
of O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
between O O
patients B-Habitat B-Habitat
with I-Habitat I-Habitat
chronic I-Habitat I-Habitat
gastritis I-Habitat I-Habitat
and O O
gastric B-Habitat B-Habitat
cancer O O
in O O
Japan O O
, O O
but O O
the O O
prevalence O O
of O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
in O O
young B-Habitat O
Japanese I-Habitat O
gastric I-Habitat B-Habitat
cancer I-Habitat I-Habitat
patients I-Habitat I-Habitat
was O O
significantly O O
higher O O
than O O
in O O
the O O
control O O
group O O
. O O

These O O
data O O
clearly O O
show O O
that O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
is O O
one O O
of O O
the O O
risk O O
factors O O
of O O
gastric B-Habitat B-Habitat
cancer O I-Habitat
in O I-Habitat
young B-Habitat I-Habitat
Japanese I-Habitat I-Habitat
people I-Habitat I-Habitat
, O O
There O O
is O O
no O O
answer O O
to O O
whether O O
curing O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
can O O
reverse O O
the O O
atrophy O O
of O O
the O O
gastric B-Habitat B-Habitat
mucosa O O
and O O
decrease O O
the O O
risk O O
of O O
gastric B-Habitat B-Habitat
cancer O I-Habitat
development O I-Habitat
. O O

To O O
clarify O O
this O O
issue O O
, O O
an O O
intervention O O
study O O
must O O
be O O
done O O
. O O

A O O
large O O
clinical O O
trial O O
called O O
the O O
Japanese O O
Intervention O O
Trial O O
of O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
is O O
in O O
progress O O
. O O

Hg O O
( O O
II O O
) O O
sequestration O O
and O O
protection O O
by O O
the O O
MerR O O
metal O O
- O O
binding O O
domain O O
( O O
MBD O O
) O O
. O O

MerR O O
, O O
the O O
metalloregulator O O
of O O
the O O
bacterial O O
mercury O O
resistance O O
( O O
mer O O
) O O
operon O O
, O O
binds O O
Hg O O
( O O
II O O
) O O
with O O
high O O
affinity O O
. O O

To O O
study O O
the O O
mechanism O O
of O O
metal O O
- O O
induced O O
activation O O
, O O
a O O
small O O
protein O O
was O O
previously O O
engineered O O
embodying O O
in O O
a O O
single O O
polypeptide O O
the O O
metal O O
- O O
binding O O
domain O O
( O O
MBD O O
) O O
ordinarily O O
formed O O
between O O
two O O
monomers O O
of O O
MerR O O
. O O

Here O O
the O O
physiological O O
and O O
biochemical O O
properties O O
of O O
MBD O O
expressed O O
on O O
the O O
cell O B-Habitat
surface O O
or O O
in O O
the O O
cytosol O O
were O O
examined O O
, O O
to O O
better O O
understand O O
the O O
environments O O
in O O
which O O
specific O O
metal O O
binding O O
can O O
occur O O
with O O
this O O
small O O
derivative O O
. O O

Over O O
20 O O
000 O O
surface O O
copies O O
of O O
MBD O O
were O O
expressed O O
per O O
Escherichia B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
cell O O
, O O
with O O
metal O O
stoichiometries O O
of O O
approximately O O
1 O O
. O O
0 O O
Hg O O
( O O
II O O
) O O
per O O
MBD O O
monomer O O
. O O

Cells O O
expressing O O
MBD O O
on O O
their O O
surface O O
in O O
rich B-Habitat O
medium I-Habitat O
bound O O
6 O O
. O O
1 O O
- O O
fold O O
more O O
Hg O O
( O O
II O O
) O O
than O O
those O O
not O O
expressing O O
MBD O O
. O O

Although O O
in O O
nature O B-Habitat
cells O I-Habitat
use O O
the O O
entire O O
mer O O
operon O O
to O O
detoxify O O
mercury O O
, O O
it O O
was O O
interesting O O
to O O
note O O
that O O
cells O O
expressing O O
only O O
MBD O O
survived O O
Hg O O
( O O
II O O
) O O
challenge O O
and O O
recovered O O
more O O
quickly O O
than O O
cells O O
without O O
MBD O O
. O O

Cell O O
- O O
surface O O
- O O
expressed O O
MBD O O
bound O O
Hg O O
( O O
II O O
) O O
preferentially O O
even O O
in O O
the O O
presence O O
of O O
a O O
22 O O
- O O
fold O O
molar O O
excess O O
of O O
Zn O O
( O O
II O O
) O O
and O O
when O O
exposed O O
to O O
equimolar O O
Cd O O
( O O
II O O
) O O
in O O
addition O O
. O O

MBD O O
expressed O O
in O O
the O O
cystosol O O
also O O
afforded O O
improved O O
survival O O
from O O
Hg O O
( O O
II O O
) O O
exposure O O
for O O
E B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
coli I-Bacteria I-Bacteria
and O O
for O O
the O O
completely O O
unrelated O O
bacterium O O
Deinococcus B-Bacteria B-Bacteria
radiodurans I-Bacteria I-Bacteria
. O O

Etiology O O
and O O
epidemiology O O
of O O
diarrhea O O
in O O
children B-Habitat B-Habitat
in O O
Hanoi O O
, O O
Vietnam O O
. O O

This O O
paper O O
provides O O
a O O
preliminary O O
picture O O
of O O
diarrhea O O
with O O
regards O O
to O O
etiology O O
, O O
clinical O O
symptoms O O
, O O
and O O
some O O
related O O
epidemiologic O O
factors O O
in O O
children B-Habitat B-Habitat
less I-Habitat I-Habitat
than I-Habitat I-Habitat
five I-Habitat I-Habitat
years I-Habitat I-Habitat
of I-Habitat I-Habitat
age I-Habitat I-Habitat
living O O
in O O
Hanoi O O
, O O
Vietnam O O
. O O

The O O
study O O
population O O
included O O
587 O O
children B-Habitat B-Habitat
with I-Habitat I-Habitat
diarrhea I-Habitat I-Habitat
and O O
249 O O
age B-Habitat O
- I-Habitat O
matched I-Habitat O
healthy I-Habitat O
controls I-Habitat O
. O O

The O O
identification O O
of O O
pathogens O O
was O O
carried O O
out O O
by O O
the O O
conventional O O
methods O O
in O O
combination O O
with O O
ELISA O O
, O O
immunoseparation O O
, O O
and O O
PCR O O
. O O

The O O
antibiotic O O
susceptibility O O
was O O
determined O O
by O O
MIC O O
following O O
the O O
NCCLS O O
recommendations O O
. O O

Of O O
those O O
with O O
diarrhea O O
, O O
40 O O
. O O
9 O O
% O O
were O O
less O O
than O O
one O O
year O O
old O O
and O O
71 O O
. O O
0 O O
% O O
were O O
less O O
than O O
two O O
years O O
old O O
. O O

A O O
potential O O
pathogen O O
was O O
identified O O
in O O
67 O O
. O O
3 O O
% O O
of O O
children B-Habitat B-Habitat
with I-Habitat I-Habitat
diarrhea I-Habitat I-Habitat
. O O

They O O
were O O
group O O
A O O
rotavirus O O
, O O
diarrheagenic O O
Escherichia B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
, O O
Shigella B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
, O O
and O O
enterotoxigenic O O
Bacteroides B-Bacteria O
fragilis I-Bacteria O
, O O
with O O
prevalences O O
of O O
46 O O
. O O
7 O O
% O O
, O O
22 O O
. O O
5 O O
% O O
, O O
4 O O
. O O
7 O O
% O O
, O O
and O O
7 O O
. O O
3 O O
% O O
, O O
respectively O O
. O O

No O O
Salmonella B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
or O O
Vibrio B-Bacteria B-Bacteria
cholerae I-Bacteria I-Bacteria
were O O
isolated O O
. O O

Rotavirus O O
and O O
diarrheagenic O O
E B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
coli I-Bacteria I-Bacteria
were O O
predominant O O
in O O
children B-Habitat B-Habitat
less I-Habitat I-Habitat
than I-Habitat I-Habitat
two I-Habitat I-Habitat
years I-Habitat I-Habitat
of I-Habitat I-Habitat
age I-Habitat I-Habitat
, O O
while O O
Shigella B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
, O O
and O O
enterotoxigenic O O
B B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
fragilis I-Bacteria I-Bacteria
were O O
mostly O O
seen O O
in O O
the O O
older B-Habitat B-Habitat
children I-Habitat I-Habitat
. O O

Diarrheagenic O O
E B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
coli I-Bacteria I-Bacteria
and O O
Shigella B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
showed O O
high O O
prevalence O O
of O O
resistance O O
to O O
ampicillin O O
, O O
chloramphenicol O O
, O O
and O O
to O O
trimethoprim O O
/ O O
sulfamethoxazole O O
. O O

Children B-Habitat O
attending I-Habitat O
the I-Habitat O
hospitals I-Habitat B-Habitat
had O O
fever O O
( O O
43 O O
. O O
6 O O
% O O
) O O
, O O
vomiting O O
( O O
53 O O
. O O
8 O O
% O O
) O O
, O O
and O O
dehydration O O
( O O
82 O O
. O O
6 O O
% O O
) O O
. O O

Watery B-Habitat O
stool I-Habitat O
was O O
predominant O O
with O O
a O O
prevalence O O
of O O
66 O O
. O O
4 O O
% O O
, O O
followed O O
by O O
mucous B-Habitat O
stool I-Habitat O
( O O
21 O O
. O O
0 O O
% O O
) O O
. O O

The O O
mean O O
episodes O O
of O O
stools B-Habitat O
per O O
day O O
was O O
seven O O
, O O
ranging O O
from O O
two O O
to O O
23 O O
episodes O O
. O O

Before O O
attending O O
hospitals B-Habitat B-Habitat
, O O
162 O O
/ O O
587 O O
( O O
27 O O
. O O
6 O O
% O O
) O O
children B-Habitat B-Habitat
had O O
been O O
given O O
antibiotics O O
. O O

Overall O O
, O O
more O O
children B-Habitat B-Habitat
got O O
diarrhea O O
in O O
( O O
i O O
) O O
poor O O
families O O
; O O
( O O
ii O O
) O O
families O O
where O O
piped B-Habitat O
water I-Habitat O
and O O
a O O
latrine B-Habitat O
were O O
lacking O O
; O O
( O O
iii O O
) O O
families O O
where O O
mothers B-Habitat O
washed O O
their O O
hands O O
less O O
often O O
before O O
feeding O O
the O O
children B-Habitat B-Habitat
; O O
( O O
iv O O
) O O
families O O
where O O
mothers B-Habitat O
had O O
a O O
low O O
level O O
of O O
education O O
; O O
( O O
v O O
) O O
families O O
where O O
information O O
on O O
health O O
and O O
sanitation O O
less O O
often O O
reached O O
their O O
households O O
. O O

Group O B-Bacteria
A O I-Bacteria
rotavirus O I-Bacteria
, O O
diarrheagenic O O
Escherichia B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
, O O
Shigella B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
, O O
and O O
enterotoxigenic O O
Bacteroides B-Bacteria O
fragilis I-Bacteria O
play O O
an O O
important O O
role O O
in O O
causing O O
diarrhea O O
in O O
children B-Habitat B-Habitat
in O O
Hanoi O O
, O O
Vietnam O O
. O O

Epidemiological O O
factors O O
such O O
as O O
lack O O
of O O
fresh B-Habitat O
water I-Habitat O
supply I-Habitat O
, O O
unhygienic B-Habitat O
septic I-Habitat O
tank I-Habitat O
, O O
low O O
family O O
income O O
, O O
lack O O
of O O
health O O
information O O
, O O
and O O
low O O
educational O O
level O O
of O O
parents O O
could O O
contribute O O
to O O
the O O
morbidity O O
of O O
diarrhea O O
in O O
children B-Habitat B-Habitat
. O O

Neutrophils B-Habitat O
are O O
resistant O O
to O O
Yersinia B-Bacteria O
YopJ O O
/ O O
P O O
- O O
induced O O
apoptosis O O
and O O
are O O
protected O O
from O O
ROS O O
- O O
mediated O O
cell B-Habitat O
death O O
by O O
the O O
type O O
III O O
secretion O O
system O O
. O O

The O O
human B-Habitat O
innate O O
immune O O
system O O
relies O O
on O O
the O O
coordinated O O
activity O O
of O O
macrophages B-Habitat B-Habitat
and O O
polymorphonuclear B-Habitat B-Habitat
leukocytes I-Habitat I-Habitat
( O O
neutrophils B-Habitat B-Habitat
or O O
PMNs B-Habitat O
) O O
for O O
defense O O
against O O
bacterial O O
pathogens O O
. O O

Yersinia B-Bacteria O
spp O O
. O O

subvert O O
the O O
innate B-Habitat O
immune I-Habitat O
response O O
to O O
cause O O
disease O O
in O O
humans B-Habitat B-Habitat
. O O

In O O
particular O O
, O O
the O O
Yersinia B-Bacteria B-Bacteria
outer O I-Bacteria
protein O O
YopJ O O
( O O
Y B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pestis I-Bacteria I-Bacteria
and O O
Y B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pseudotuberculosis I-Bacteria I-Bacteria
) O O
and O O
YopP O O
( O O
Y B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
enterocolitica I-Bacteria I-Bacteria
) O O
rapidly O O
induce O O
apoptosis O O
in O O
murine B-Habitat B-Habitat
macrophages I-Habitat I-Habitat
and O I-Habitat
dendritic O I-Habitat
cells O I-Habitat
. O O

However O O
, O O
the O O
effects O O
of O O
Yersinia B-Bacteria B-Bacteria
Yop O I-Bacteria
J O I-Bacteria
/ O I-Bacteria
P O I-Bacteria
on O O
neutrophil B-Habitat B-Habitat
fate O O
are O O
not O O
clearly O O
defined O O
. O O

In O O
this O O
study O O
, O O
we O O
utilized O O
wild O O
- O O
type O O
and O O
mutant O O
strains O O
of O O
Yersinia B-Bacteria O
to O O
test O O
the O O
contribution O O
of O O
YopJ O O
and O O
YopP O O
on O O
induction O O
of O O
apoptosis O O
in O O
human B-Habitat B-Habitat
monocyte O I-Habitat
- O I-Habitat
derived O I-Habitat
macrophages O I-Habitat
( O O
HMDM B-Habitat O
) O O
and O O
neutrophils B-Habitat B-Habitat
. O O

Whereas O O
YopJ O O
and O O
YopP O O
similarly O O
induced O O
apoptosis O O
in O O
HMDMs B-Habitat O
, O O
interaction O O
of O O
human B-Habitat B-Habitat
neutrophils O B-Habitat
with O O
virulence O O
plasmid O O
- O O
containing O O
Yersinia B-Bacteria O
did O O
not O O
result O O
in O O
PMN B-Habitat O
caspase O O
activation O O
, O O
release O O
of O O
LDH O O
, O O
or O O
loss O O
of O O
membrane O O
integrity O O
greater O O
than O O
PMN B-Habitat O
controls O O
. O O

In O O
contrast O O
, O O
interaction O O
of O O
human B-Habitat B-Habitat
PMNs B-Habitat I-Habitat
with O I-Habitat
the O I-Habitat
virulence O I-Habitat
plasmid O I-Habitat
- O I-Habitat
deficient O I-Habitat
Y B-Bacteria I-Habitat
. I-Bacteria I-Habitat
pestis I-Bacteria I-Habitat
strain I-Bacteria I-Habitat
KIM6 I-Bacteria I-Habitat
resulted O O
in O O
increased O B-Habitat
surface O I-Habitat
exposure O I-Habitat
of O I-Habitat
phosphatidylserine O I-Habitat
( O O
PS O O
) O O
and O O
cell B-Habitat O
death O O
. O O

PMN B-Habitat O
reactive O O
oxygen O O
species O O
( O O
ROS O O
) O O
production O O
was O O
inhibited O O
in O O
a O O
virulence O O
plasmid O O
- O O
dependent O O
but O O
YopJ O O
/ O O
YopP O O
- O O
independent O O
manner O O
. O O

Following O O
phagocytic O O
interaction O O
with O O
Y B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pestis I-Bacteria I-Bacteria
strain I-Bacteria I-Bacteria
KIM6 I-Bacteria I-Bacteria
, O O
inhibition O O
of O O
PMN B-Habitat B-Habitat
ROS O I-Habitat
production O I-Habitat
with O I-Habitat
diphenyleneiodonium O I-Habitat
chloride O I-Habitat
resulted O O
in O O
a O O
reduction O O
of O O
PMN B-Habitat B-Habitat
cell I-Habitat I-Habitat
death O O
similar O O
to O O
that O O
induced O O
by O O
the O O
virulence O O
plasmid O O
- O O
containing O O
strain O O
Y B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pestis I-Bacteria I-Bacteria
KIM5 I-Bacteria I-Bacteria
. O O

Our O O
findings O O
showed O O
that O O
Yersinia B-Bacteria B-Bacteria
YopJ O I-Bacteria
and O O
/ O O
or O O
YopP O O
did O O
not O O
induce O O
pronounced O O
apoptosis O O
in O O
human B-Habitat B-Habitat
neutrophils O I-Habitat
. O O

Furthermore O O
, O O
robust O O
PMN B-Habitat O
ROS O O
production O O
in O O
response O O
to O O
virulence O O
plasmid O O
- O O
deficient O O
Yersinia B-Bacteria O
was O O
associated O O
with O O
increased O O
PMN B-Habitat O
cell I-Habitat O
death O O
, O O
suggesting O O
that O O
Yersinia B-Bacteria O
inhibition O O
of O O
PMN B-Habitat O
ROS O O
production O O
plays O O
a O O
role O O
in O O
evasion O O
of O O
the O O
human B-Habitat B-Habitat
innate I-Habitat O
immune I-Habitat O
response O O
in O O
part O O
by O O
limiting O O
PMN B-Habitat O
apoptosis O O
. O O

Lymphogranuloma O B-Bacteria
venereum O I-Bacteria
presenting O O
as O O
perianal B-Habitat O
ulceration O O
: O O
an O O
emerging O O
clinical O O
presentation O O
? O O

An O O
outbreak O O
of O O
lymphogranuloma O O
venereum O O
( O O
LGV O O
) O O
infection O O
has O O
been O O
recognised O O
in O O
the O O
UK O O
since O O
2004 O O
, O O
predominantly O O
affecting O O
HIV B-Habitat O
- I-Habitat O
positive I-Habitat O
men I-Habitat O
who I-Habitat O
have I-Habitat O
sex I-Habitat O
with I-Habitat O
men I-Habitat O
( O O
MSM B-Habitat O
) O O
. O O

Patients B-Habitat B-Habitat
typically O O
present O O
with O O
proctitis O O
symptoms O O
. O O

The O O
prevalence O O
of O O
rectal B-Habitat O
LGV O O
in O O
MSM B-Habitat O
attending I-Habitat O
sexually I-Habitat O
transmitted I-Habitat O
infection I-Habitat O
clinics I-Habitat O
in O O
London O O
is O O
estimated O O
at O O
1 O O
% O O
. O O

Health O O
Protection O O
Agency O O
surveillance O O
has O O
shown O O
a O O
decrease O O
in O O
anorectal B-Habitat O
manifestations O O
despite O O
little O O
demographic O O
change O O
. O O

Two O O
cases O O
of O O
HIV B-Habitat O
- I-Habitat O
infected I-Habitat O
patients I-Habitat B-Habitat
presenting I-Habitat O
with I-Habitat O
isolated I-Habitat O
perianal I-Habitat O
ulcer I-Habitat O
disease I-Habitat O
are O O
reported O O
here O O
. O O

Both O O
cases O O
were O O
confirmed O O
to O O
have O O
rectal B-Habitat O
Chlamydia B-Bacteria B-Bacteria
trachomatis I-Bacteria I-Bacteria
- O O
specific O O
DNA O O
of O O
an O O
LGV O O
associated O O
serovar O O
. O O

As O O
presentations O O
of O O
LGV O O
diversify O O
, O O
further O O
education O O
and O O
surveillance O O
are O O
needed O O
in O O
order O O
to O O
reduce O O
transmission O O
and O O
prevent O O
long O O
- O O
term O O
complications O O
. O O

A O O
strong O O
argument O O
already O O
exists O O
for O O
the O O
incorporation O O
of O O
chlamydia B-Bacteria O
nucleic O O
acid O O
amplification O O
tests O O
in O O
the O O
management O O
of O O
MSM B-Habitat O
with I-Habitat O
proctitis I-Habitat O
; O O
this O O
paper O O
provides O O
evidence O O
that O O
this O O
should O O
be O O
extended O O
to O O
MSM B-Habitat O
with I-Habitat O
perianal I-Habitat O
ulcer I-Habitat O
disease I-Habitat O
. O O

Quantitative O O
metabolome O O
analysis O O
using O O
liquid O O
chromatography O O
- O O
high O O
- O O
resolution O O
mass O O
spectrometry O O
. O O

In O O
this O O
report O O
, O O
we O O
introduce O O
a O O
liquid O O
chromatography O O
single O O
- O O
mass O O
spectrometry O O
method O O
for O O
metabolome O O
quantification O O
, O O
using O O
the O O
LTQ B-Habitat O
Orbitrap I-Habitat O
high I-Habitat O
- I-Habitat O
resolution I-Habitat O
mass I-Habitat O
spectrometer I-Habitat O
. O O

Analytes O O
were O O
separated O O
with O O
hydrophilic O O
interaction O O
liquid O O
chromatography O O
. O O

At O O
a O O
working O O
resolution O O
of O O
30 O O
, O O
000 O O
( O O
at O O
m O O
/ O O
z O O
400 O O
) O O
, O O
the O O
limit O O
of O O
detection O O
varied O O
from O O
50 O O
fmol O O
to O O
5 O O
pmol O O
for O O
25 O O
metabolites O O
tested O O
. O O

In O O
terms O O
of O O
metabolite O O
concentration O O
, O O
the O O
linearity O O
was O O
about O O
2 O O
to O O
3 O O
orders O O
of O O
magnitude O O
for O O
most O O
compounds O O
( O O
R O O
( O O
2 O O
) O O
> O O
0 O O
. O O
99 O O
) O O
. O O

To O O
determine O O
the O O
accuracy O O
of O O
the O O
system O O
in O O
complex O B-Habitat
sample O I-Habitat
matrices O I-Habitat
, O O
the O O
isotope O O
dilution O O
method O O
was O O
evaluated O O
from O O
mixtures B-Habitat O
of I-Habitat O
pure I-Habitat O
compounds I-Habitat O
and I-Habitat O
uniformly I-Habitat O
13C I-Habitat B-Habitat
- I-Habitat I-Habitat
labeled I-Habitat I-Habitat
cell I-Habitat I-Habitat
extracts I-Habitat I-Habitat
. O O

With O O
the O O
application O O
of O O
this O O
method O O
, O O
quantification O O
was O O
possible O O
within O O
single O O
runs O O
even O O
when O O
the O O
pool O O
sizes O O
of O O
individual O O
metabolites O O
varied O O
from O O
0 O O
. O O
13 O O
to O O
55 O O
. O O
6 O O
microM O O
. O O

As O O
a O O
case O O
study O O
, O O
intracellular O O
concentrations O O
of O O
central O B-Habitat
metabolites O I-Habitat
were O O
determined O O
for O O
Methylobacterium B-Bacteria B-Bacteria
extorquens I-Bacteria I-Bacteria
AM1 I-Bacteria I-Bacteria
during O O
growth O O
on O O
two O O
different O O
carbon O O
sources O O
, O O
methanol O O
and O O
succinate O O
. O O

Reproducible O O
results O O
from O O
technical O O
and O O
biological O O
repetitions O O
were O O
obtained O O
that O O
revealed O O
significant O O
variations O O
of O O
intracellular O O
metabolite O O
pool O O
sizes O O
, O O
depending O O
on O O
the O O
carbon O O
source O O
. O O

The O O
LTQ B-Habitat O
Obitrap I-Habitat O
offers O O
new O O
perspectives O O
and O O
strategies O O
for O O
metabolome O O
quantification O O
. O O

Atypical O O
mycobacteria B-Bacteria O
causing O O
non O O
- O O
pulmonary B-Habitat O
disease O O
in O O
Queensland O O
. O O

During O O
the O O
period O O
1971 O O
- O O
- O O
7 O O
, O O
the O O
Tuberculosis O O
Reference O O
Laboratory O O
in O O
Queensland O O
dealt O O
with O O
52 O O
isolates O O
of O O
atypical O O
mycobacteria B-Bacteria B-Bacteria
made O O
from O O
non O O
- O O
pulmonary B-Habitat O
sites O O
under O O
circumstances O O
suggesting O O
complicity O O
in O O
disease O O
. O O

Twenty O O
- O O
four O O
isolates O O
belonging O O
to O O
the O O
MAIS O O
complex O O
were O O
associated O O
with O O
lymph B-Habitat O
node I-Habitat O
infections O O
in O O
children B-Habitat B-Habitat
. O O

Twelve O O
isolates O O
belonged O O
to O O
the O O
M B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
fortuitum I-Bacteria I-Bacteria
- I-Bacteria O
chelonei I-Bacteria O
complex I-Bacteria O
; O O
most O O
were O O
from O O
superficial B-Habitat O
abscesses I-Habitat O
. O O

Five O O
cases O O
of O O
M B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
marinum I-Bacteria I-Bacteria
infection O O
and O O
8 O O
of O O
M B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
ulcerans I-Bacteria I-Bacteria
disease O O
were O O
detected O O
. O O

Serotypes O O
of O O
Vibrio B-Bacteria B-Bacteria
parahaemolyticus I-Bacteria I-Bacteria
from O O
clinical B-Habitat O
and O O
environmental O O
sources O O
in O O
Togo O O
( O O
West O O
Africa O O
) O O
. O O

Serological O O
analysis O O
of O O
O O O
and O O
K O O
antigens O O
was O O
performed O O
on O O
343 O O
strains O O
of O O
Vibro B-Bacteria B-Bacteria
parahaemolyticus I-Bacteria I-Bacteria
isolated O O
from O O
clinical B-Habitat O
and O O
environmental O O
sources O O
in O O
Togo O O
. O O

Only O O
two O O
strains O O
were O O
not O O
typable O O
by O O
the O O
available O O
O O O
antisera O O
. O O

K O O
untypable O O
strains O O
were O O
found O O
in O O
4 O O
. O O
8 O O
% O O
of O O
isolates O O
from O O
gastroenteritis B-Habitat B-Habitat
patients I-Habitat I-Habitat
, O O
in O O
11 O O
% O O
from O O
healthy B-Habitat O
carriers I-Habitat O
, O O
and O O
in O O
47 O O
% O O
and O O
46 O O
% O O
of O O
isolates O O
, O O
respectively O O
, O O
from O O
water B-Habitat O
and O O
fish B-Habitat B-Habitat
samples I-Habitat I-Habitat
. O O

Thirteen O O
serotypes O O
identified O O
in O O
Togo O O
are O O
not O O
considered O O
in O O
the O O
Japanese O O
antigenic O O
scheme O O
. O O

The O O
suitability O O
of O O
the O O
Japanese O O
typing O O
scheme O O
for O O
geographic O O
areas O O
outside O O
of O O
Japan O O
is O O
discussed O O
and O O
its O O
extension O O
is O O
suggested O O
. O O

Enhanced O O
virulence O O
of O O
Chlamydia B-Bacteria B-Bacteria
muridarum I-Bacteria I-Bacteria
respiratory B-Habitat I-Bacteria
infections O O
in O O
the O O
absence O O
of O O
TLR2 O O
activation O O
. O O

Chlamydia B-Bacteria B-Bacteria
trachomatis I-Bacteria I-Bacteria
is O O
a O O
common O O
sexually O O
transmitted O O
pathogen O O
and O O
is O O
associated O O
with O O
infant B-Habitat O
pneumonia O O
. O O

Data O O
from O O
the O O
female B-Habitat O
mouse I-Habitat O
model O O
of O O
genital B-Habitat B-Habitat
tract I-Habitat I-Habitat
chlamydia B-Bacteria I-Habitat
infection O O
suggests O O
a O O
requirement O O
for O O
TLR2 O O
- O O
dependent O O
signaling O O
in O O
the O O
induction O O
of O O
inflammation O O
and O O
oviduct B-Habitat O
pathology O O
. O O

We O O
hypothesized O O
that O O
the O O
role O O
of O O
TLR2 O O
in O O
moderating O O
mucosal B-Habitat O
inflammation O O
is O O
site O O
specific O O
. O O

In O O
order O O
to O O
investigate O O
this O O
, O O
we O O
infected O O
mice B-Habitat O
via O O
the O O
intranasal B-Habitat O
route O O
with O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
muridarum I-Bacteria I-Bacteria
and O O
observed O O
that O O
in O O
the O O
absence O O
of O O
TLR2 O O
activation O O
, O O
mice B-Habitat O
had O O
more O O
severe O O
disease O O
, O O
higher O O
lung B-Habitat O
cytokine O O
levels O O
, O O
and O O
an O O
exaggerated O O
influx O O
of O O
neutrophils B-Habitat B-Habitat
and O O
T B-Habitat B-Habitat
- I-Habitat I-Habitat
cells I-Habitat I-Habitat
into O O
the O O
lungs B-Habitat O
. O O

This O O
could O O
not O O
be O O
explained O O
by O O
impaired O O
bacterial O O
clearance O O
as O O
TLR2 B-Habitat B-Habitat
- I-Habitat I-Habitat
deficient I-Habitat I-Habitat
mice I-Habitat I-Habitat
cleared O O
the O O
infection O O
similar O O
to O O
controls O O
. O O

These O O
data O O
suggest O O
that O O
TLR2 O O
has O O
an O O
anti O O
- O O
inflammatory O O
function O O
in O O
the O O
lung B-Habitat O
during O O
Chlamydia B-Bacteria B-Bacteria
infection O O
, O O
and O O
that O O
the O O
role O O
of O O
TLR2 O O
in O O
mucosal B-Habitat O
inflammation O O
varies O O
at O O
different O O
mucosal B-Habitat O
surfaces I-Habitat O
. O O

Evaluation O O
of O O
the O O
role O O
of O O
Carnobacterium B-Bacteria B-Bacteria
piscicola I-Bacteria I-Bacteria
in O O
spoilage O O
of O O
vacuum B-Habitat O
- I-Habitat O
and I-Habitat O
modified I-Habitat O
- I-Habitat O
atmosphere I-Habitat O
- I-Habitat O
packed I-Habitat O
cold I-Habitat O
- I-Habitat O
smoked I-Habitat O
salmon I-Habitat O
stored I-Habitat O
at I-Habitat O
5 I-Habitat O
degrees I-Habitat O
C I-Habitat O
. O O

The O O
microflora B-Habitat O
on O O
spoiled B-Habitat O
cold I-Habitat O
- I-Habitat O
smoked I-Habitat O
salmon I-Habitat O
often O O
consists O O
of O O
a O O
mixture O O
of O O
lactic B-Bacteria O
acid I-Bacteria O
bacteria I-Bacteria O
( O O
LAB B-Bacteria O
) O O
and O O
Gram O O
- O O
negative O O
bacteria O O
. O O

To O O
elucidate O O
the O O
role O O
of O O
the O O
different O O
groups O O
, O O
a O O
storage O O
trial O O
was O O
carried O O
out O O
in O O
which O O
nisin O O
and O O
CO2 O O
were O O
used O O
for O O
the O O
selective O O
inhibition O O
of O O
the O O
two O O
bacterial O O
groups O O
. O O

The O O
shelf O O
- O O
life O O
of O O
vacuum B-Habitat O
- I-Habitat O
packed I-Habitat O
cold I-Habitat O
- I-Habitat O
smoked I-Habitat O
salmon I-Habitat O
, O O
recorded O O
by O O
sensory O O
evaluation O O
, O O
was O O
four O O
weeks O O
at O O
5 O O
degrees O O
C O O
and O O
the O O
microflora B-Habitat O
was O O
composed O O
of O O
LAB B-Bacteria O
( O O
10 O O
( O O
6 O O
) O O
- O O
10 O O
( O O
7 O O
) O O
cfu O O
/ O O
g O O
) O O
with O O
an O O
associate O O
Gram O O
- O O
negative O O
flora O O
in O O
varying O O
levels O O
( O O
10 O O
( O O
5 O O
) O O
- O O
10 O O
( O O
7 O O
) O O
cfu O O
/ O O
g O O
) O O
. O O

The O O
addition O O
of O O
nisin O O
and O O
/ O O
or O O
a O O
CO2 O O
- O O
atmosphere O O
increased O O
the O O
shelf O O
- O O
life O O
to O O
five O O
or O O
six O O
weeks O O
and O O
limited O O
the O O
level O O
of O O
LAB B-Bacteria O
to O O
about O O
10 O O
( O O
4 O O
) O O
- O O
10 O O
( O O
6 O O
) O O
, O O
10 O O
( O O
3 O O
) O O
- O O
10 O O
( O O
6 O O
) O O
and O O
10 O O
( O O
2 O O
) O O
- O O
10 O O
( O O
4 O O
) O O
cfu O O
/ O O
g O O
, O O
respectively O O
. O O

CO2 O O
- O O
atmosphere O O
+ O O
/ O O
- O O
nisin O O
inhibited O O
the O O
growth O O
of O O
Gram O O
- O O
negative O O
bacteria O O
, O O
whereas O O
nisin O O
had O O
no O O
effect O O
on O O
these O O
in O O
vacuum B-Habitat B-Habitat
packages I-Habitat O
. O O

The O O
Gram O O
- O O
negative O O
flora O O
on O O
vacuum B-Habitat B-Habitat
- I-Habitat I-Habitat
packed I-Habitat I-Habitat
salmon I-Habitat I-Habitat
was O O
dominated O O
by O O
a O O
Vibrio B-Bacteria B-Bacteria
sp I-Bacteria I-Bacteria
. I-Bacteria O
, O O
resembling O O
V B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
marinus I-Bacteria I-Bacteria
, O O
Enterobacteriaceae B-Bacteria B-Bacteria
( O O
Enterobacter B-Bacteria B-Bacteria
agglomerans I-Bacteria I-Bacteria
, O O
Serratia B-Bacteria B-Bacteria
liquefaciens I-Bacteria I-Bacteria
and O O
Rahnella B-Bacteria B-Bacteria
aquatilis I-Bacteria I-Bacteria
) O O
and O O
occasionally O O
Aeromonas B-Bacteria B-Bacteria
hydrophila I-Bacteria I-Bacteria
. O O

Irrespective O O
of O O
the O O
addition O O
of O O
nisin O O
and O O
/ O O
or O O
CO2 O O
- O O
atmosphere O O
, O O
the O O
LAB B-Habitat O
microflora I-Habitat O
was O O
dominated O O
by O O
Carnobacterium B-Bacteria B-Bacteria
piscicola I-Bacteria I-Bacteria
, O O
which O O
was O O
found O O
to O O
account O O
for O O
87 O O
% O O
of O O
the O O
255 O O
LAB B-Bacteria O
isolates O O
characterized O O
. O O

Whole O O
- O O
cell O O
- O O
protein O O
patterns O O
analysed O O
by O O
SDS O O
- O O
PAGE O O
confirmed O O
the O O
Carnobacterium B-Bacteria B-Bacteria
species O O
identification O O
. O O

The O O
spoilage O O
potential O O
of O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
piscicola I-Bacteria I-Bacteria
isolates O O
was O O
further O O
studied O O
by O O
inoculation O O
of O O
approx O O
. O O

10 O O
( O O
6 O O
) O O
cfu O O
/ O O
g O O
in O O
cold B-Habitat B-Habitat
- I-Habitat I-Habitat
smoked I-Habitat I-Habitat
salmon I-Habitat I-Habitat
stored I-Habitat O
at I-Habitat O
5 I-Habitat O
degrees I-Habitat O
C I-Habitat O
. O O
The O O
salmon B-Habitat O
did O O
not O O
spoil O O
within O O
4 O O
weeks O O
of O O
storage O O
in O O
vacuum O B-Habitat
- O O
or O O
CO2 O O
- O O
atmosphere O O
, O O
and O O
it O O
is O O
concluded O O
that O O
despite O O
high O O
levels O O
( O O
> O O
10 O O
( O O
7 O O
) O O
cfu O O
/ O O
g O O
) O O
of O O
C B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
piscicola I-Bacteria I-Bacteria
, O O
sensory O O
rejection O O
was O O
caused O O
by O O
autolytic O O
changes O O
. O O

This O O
was O O
supported O O
by O O
the O O
development O O
of O O
soft O O
texture O O
and O O
sour O O
, O O
rancid O O
and O O
bitter O O
off O O
- O O
flavours O O
at O O
the O O
point O O
of O O
spoilage O O
, O O
irrespective O O
of O O
the O O
length O O
of O O
shelf O O
- O O
life O O
and O O
low O O
or O O
high O O
total O O
counts O O
of O O
LAB B-Bacteria O
and O O
Gram O O
- O O
negative O O
bacteria O O
. O O

Recurrence O O
of O O
Helicobacter B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
1 O O
year O O
after O O
successful O O
treatment O O
: O O
prospective O O
cohort O O
study O O
in O O
the O O
Republic O O
of O O
Yemen O O
. O O

To O O
investigate O O
the O O
prevalence O O
of O O
Helicobacter B-Bacteria B-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
in O O
dyspeptic B-Habitat B-Habitat
patients I-Habitat I-Habitat
in O O
the O O
Republic O O
of O O
Yemen O O
and O O
the O O
recurrence O O
rate O O
1 O O
year O O
after O O
apparently O O
successful O O
eradication O O
. O O

A O O
total O O
of O O
275 O O
patients B-Habitat B-Habitat
with I-Habitat I-Habitat
chronic I-Habitat I-Habitat
dyspepsia I-Habitat I-Habitat
seen O I-Habitat
in O I-Habitat
one O I-Habitat
clinic B-Habitat I-Habitat
were O O
enrolled O O
. O O

Gastric B-Habitat B-Habitat
biopsies I-Habitat I-Habitat
were O O
obtained O O
at O O
endoscopy O O
and O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
was O O
diagnosed O O
using O O
the O O
rapid O O
urease O O
test O O
. O O

Patients B-Habitat B-Habitat
with I-Habitat I-Habitat
H I-Habitat I-Habitat
. I-Habitat I-Habitat
pylori I-Habitat I-Habitat
infection I-Habitat O
were O O
given O O
either O O
clarithromycin O O
or O O
metronidazole O B-Habitat
- O I-Habitat
based O I-Habitat
triple O I-Habitat
therapy O I-Habitat
. O O

Six O O
weeks O O
later O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
status O O
was O O
assessed O O
using O O
the O O
C O O
- O O
urea O O
breath O O
test O O
( O O
C O O
- O O
UBT O O
) O O
. O O

Those O O
who O O
were O O
negative O O
for O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
had O O
a O O
further O O
C O O
- O O
UBT O O
after O O
1 O O
year O O
to O O
establish O O
the O O
recurrence O O
rate O O
. O O

The O O
prevalence O O
of O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
at O O
entry O O
to O O
the O O
study O O
was O O
82 O O
. O O
2 O O
% O O
[ O O
95 O O
% O O
confidence O O
interval O O
( O O
CI O O
) O O
78 O O
- O O
87 O O
% O O
] O O
. O O

The O O
overall O O
eradication O O
rate O O
6 O O
weeks O O
after O O
treatment O O
was O O
49 O O
. O O
1 O O
% O O
( O O
95 O O
% O O
CI O O
42 O O
. O O
6 O O
- O O
55 O O
. O O
6 O O
% O O
) O O
by O O
intention O O
- O O
to O O
- O O
treat O O
analysis O O
, O O
and O O
60 O O
% O O
( O O
95 O O
% O O
CI O O
53 O O
- O O
67 O O
% O O
) O O
by O O
per O O
- O O
protocol O O
analysis O O
. O O

Recurrence O O
rate O O
of O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
at O O
1 O O
year O O
was O O
34 O O
% O O
( O O
95 O O
% O O
CI O O
14 O O
- O O
45 O O
% O O
) O O
and O O
the O O
only O O
predictor O O
of O O
recurrence O O
was O O
an O O
excess O O
delta O O
C O O
- O O
UBT O O
value O O
less O O
than O O
3 O O
. O O
5 O O
per O O
million O O
but O O
equal O O
to O O
or O O
greater O O
than O O
2 O O
. O O
5 O O
per O O
million O O
at O O
6 O O
weeks O O
after O O
treatment O O
( O O
odds O O
ratio O O
2 O O
. O O
28 O O
; O O
95 O O
% O O
CI O O
1 O O
. O O
17 O O
- O O
4 O O
. O O
44 O O
; O O
P O O
= O O
0 O O
. O O
028 O O
) O O
. O O

The O O
prevalence O O
of O O
H B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
pylori I-Bacteria I-Bacteria
infection O O
in O O
dyspeptic B-Habitat B-Habitat
patients I-Habitat I-Habitat
in O O
Yemen O O
is O O
very O O
high O O
, O O
the O O
eradication O O
rate O O
with O O
standard O O
triple O O
therapy O O
was O O
unsatisfactory O O
probably O O
because O O
of O O
widespread O O
bacterial O O
resistance O O
due O O
to O O
unrestricted O O
antibiotic O O
use O O
. O O

The O O
recurrence O O
rate O O
of O O
infection O O
at O O
1 O O
year O O
was O O
high O O
, O O
as O O
a O O
result O O
of O O
recrudescence O O
of O O
incompletely O O
eradicated O O
organisms O O
rather O O
than O O
reinfection O O
. O O

Bile B-Habitat O
resistance O O
in O O
Lactococcus B-Bacteria B-Bacteria
lactis I-Bacteria I-Bacteria
strains O O
varies O O
with O O
cellular O O
fatty O O
acid O O
composition O O
: O O
analysis O O
by O O
using O O
different O O
growth O O
media O O
. O O

Bile B-Habitat O
resistance O O
is O O
one O O
of O O
the O O
basic O O
characteristics O O
of O O
probiotic O O
bacteria O O
. O O

The O O
aim O O
of O O
this O O
study O O
was O O
to O O
investigate O O
the O O
characteristics O O
of O O
bile B-Habitat O
resistance O O
in O O
lactococci B-Bacteria O
by O O
studying O O
the O O
relationship O O
between O O
bile B-Habitat O
resistance O O
and O O
cellular O O
fatty O O
acid O O
composition O O
in O O
lactococcci B-Bacteria O
grown O O
on O O
different O O
media O O
. O O

We O O
determined O O
the O O
bile B-Habitat O
resistance O O
of O O
14 O O
strains O O
in O O
lactose O B-Habitat
- O I-Habitat
free O I-Habitat
M17 O I-Habitat
medium O I-Habitat
supplemented O O
with O O
either O O
glucose O O
only O O
( O O
GM17 O O
) O O
or O O
lactose O O
only O O
( O O
LM17 O O
) O O
. O O

Gas O O
chromatographic O O
analyses O O
of O O
free O O
lipids O O
extracted O O
from O O
the O O
tested O O
strains O O
were O O
used O O
for O O
determining O O
their O O
fatty O O
acid O O
composition O O
. O O

A O O
correlation O O
analysis O O
of O O
all O O
strains O O
grown O O
in O O
both O O
media O O
revealed O O
significant O O
positive O O
correlations O O
between O O
bile B-Habitat O
resistance O O
and O O
relative O O
contents O O
of O O
hexadecanoic O O
acid O O
and O O
octadecenoic O O
acid O O
, O O
and O O
negative O O
correlations O O
between O O
bile B-Habitat O
resistance O O
and O O
relative O O
contents O O
of O O
hexadecenoic O O
acid O O
and O O
C O O
- O O
19 O O
cyclopropane O O
fatty O O
acid O O
. O O

It O O
is O O
also O O
a O O
fact O O
that O O
the O O
fatty O O
acids O O
associated O O
with O O
bile B-Habitat O
resistance O O
depended O O
on O O
species O O
, O O
strain O O
, O O
and O O
/ O O
or O O
growth O O
medium O O
. O O

In O O
L B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
lactis I-Bacteria I-Bacteria
subsp I-Bacteria I-Bacteria
. I-Bacteria I-Bacteria
Bacteria_I I-Bacteria I-Bacteria
cremoris O I-Bacteria
strains O O
grown O O
in O O
GM17 B-Habitat B-Habitat
medium I-Habitat I-Habitat
, O O
the O O
bile B-Habitat O
- O O
resistant O O
strains O O
had O O
significantly O O
more O O
octadecenoic O O
acid O O
than O O
the O O
bile B-Habitat O
- O O
sensitive O O
strains O O
. O O

In O O
LM17 B-Habitat O
medium I-Habitat O
, O O
bile B-Habitat O
- O O
resistant O O
strains O O
had O O
significantly O O
more O O
octadecenoic O O
acid O O
and O O
significantly O O
less O O
C O O
- O O
19 O O
cyclopropane O O
fatty O O
acid O O
than O O
the O O
bile B-Habitat O
- O O
sensitive O O
strains O O
. O O

In O O
L B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
lactis I-Bacteria I-Bacteria
subsp I-Bacteria I-Bacteria
. I-Bacteria I-Bacteria
Bacteria_I I-Bacteria I-Bacteria
lactis O I-Bacteria
strains O O
, O O
bile B-Habitat O
resistances O O
of O O
some O O
of O O
the O O
tested O O
strains O O
were O O
altered O O
by O O
growth O O
medium O O
. O O

Some O O
strains O O
were O O
resistant O O
to O O
bile B-Habitat O
in O O
GM17 B-Habitat B-Habitat
medium I-Habitat I-Habitat
but O O
sensitive O O
to O O
bile B-Habitat O
in O O
LM17 B-Habitat B-Habitat
medium I-Habitat I-Habitat
. O O

Some O O
strains O O
were O O
resistant O O
in O O
both O O
media O O
tested O O
. O O

The O O
strains O O
grown O O
in O O
GM17 B-Habitat B-Habitat
medium I-Habitat I-Habitat
had O O
significantly O O
more O O
hexadecanoic O O
acid O O
and O O
octadecenoic O O
acid O O
, O O
and O O
significantly O O
less O O
tetradecanoic O O
acid O O
, O O
octadecadienoic O O
acid O O
and O O
C O O
- O O
19 O O
cyclopropane O O
fatty O O
acid O O
than O O
the O O
strains O O
grown O O
in O O
LM17 B-Habitat B-Habitat
medium I-Habitat I-Habitat
. O O

In O O
conclusion O O
, O O
the O O
fatty O O
acid O O
compositions O O
of O O
the O O
bile B-Habitat O
- O O
resistant O O
lactococci B-Bacteria O
differed O O
from O O
those O O
of O O
the O O
bile B-Habitat O
- O O
sensitive O O
ones O O
. O O

More O O
importantly O O
, O O
our O O
data O O
suggest O O
that O O
altering O O
their O O
fatty O O
acid O O
composition O O
( O O
i O O
. O O
e O O
. O O

increased O O
hexadecanoic O O
acid O O
and O O
octadecenoic O O
acid O O
and O O
decreased O O
hexadecenoic O O
acid O O
and O O
C O O
- O O
19 O O
cyclopropane O O
fatty O O
acid O O
) O O
by O O
changing O O
growth O O
conditions O O
may O O
be O O
a O O
useful O O
way O O
to O O
enhance O O
their O O
bile B-Habitat O
resistance O O
in O O
lactococci B-Bacteria O
. O O

Early O O
pregnancy O O
loss O O
and O O
neonatal B-Habitat O
deaths O O
associated O O
with O O
Klebsiella B-Bacteria B-Bacteria
pneumonia I-Bacteria I-Bacteria
infection O O
: O O
a O O
mini O O
review O O
of O O
possible O O
occupational O O
health O O
risk O O
. O O

Recurrent O O
pregnancy O O
loss O O
is O O
a O O
disease O O
of O O
grave O O
psychological O O
and O O
economic O O
concern O O
. O O

The O O
etiology O O
in O O
the O O
vast O O
majority O O
of O O
the O O
cases O O
is O O
unknown O O
or O O
at O O
best O O
poorly O O
understood O O
. O O

Although O O
Klebsiella B-Bacteria B-Bacteria
pneumonia I-Bacteria I-Bacteria
infections O O
have O O
been O O
reported O O
in O O
humans B-Habitat B-Habitat
and O O
animals B-Habitat B-Habitat
during O O
pregnancy O O
, O O
there O O
is O O
hardly O O
any O O
information O O
to O O
indicate O O
whether O O
or O O
not O O
these O O
infections O O
may O O
be O O
responsible O O
for O O
early O O
pregnancy O O
loss O O
. O O

We O O
present O O
a O O
review O O
of O O
literature O O
and O O
report O O
for O O
the O O
first O O
time O O
in O O
humans B-Habitat B-Habitat
, O O
Klebsiella B-Bacteria B-Bacteria
pneumonia I-Bacteria I-Bacteria
infection O O
in O O
placenta B-Habitat O
of I-Habitat O
a I-Habitat O
38 I-Habitat O
- I-Habitat O
year I-Habitat O
- I-Habitat O
old I-Habitat O
secondary I-Habitat O
recurrent I-Habitat O
aborter I-Habitat O
( O O
parity O O
2 O O
+ O O
3 O O
) O O
. O O

Vibrio B-Bacteria B-Bacteria
fetus I-Bacteria I-Bacteria
human B-Habitat I-Bacteria
infection O O
- O O
- O O
isolation O O
from O O
a O O
subacute O O
bacterial O O
endocarditis O O
case O O
. O O

Effects O O
of O O
a O O
probiotic B-Habitat O
fermented I-Habitat O
milk I-Habitat O
beverage I-Habitat O
containing O O
Lactobacillus B-Bacteria B-Bacteria
casei I-Bacteria I-Bacteria
strain I-Bacteria O
Shirota I-Bacteria O
on O O
defecation O O
frequency O O
, O O
intestinal B-Habitat B-Habitat
microbiota I-Habitat I-Habitat
, O O
and O O
the O O
intestinal B-Habitat O
environment I-Habitat O
of I-Habitat O
healthy I-Habitat B-Habitat
individuals I-Habitat I-Habitat
with I-Habitat I-Habitat
soft I-Habitat I-Habitat
stools I-Habitat I-Habitat
. O O

The O O
effects O O
of O O
drinking O O
a O O
fermented B-Habitat O
milk I-Habitat O
beverage I-Habitat O
that O O
contains O O
Lactobacillus B-Bacteria O
casei I-Bacteria O
strain I-Bacteria O
Shirota I-Bacteria O
( O O
LcS B-Bacteria O
) O O
at O O
40 O O
billion O O
bacterial O O
cells O O
/ O O
bottle B-Habitat O
for O O
4 O O
weeks O O
( O O
probiotics B-Habitat O
, O O
1 O O
bottle B-Habitat O
/ O O
day O O
) O O
on O O
defecation O O
frequency O O
, O O
intestinal B-Habitat B-Habitat
microbiota O I-Habitat
and O O
the O O
intestinal B-Habitat O
environment I-Habitat O
of I-Habitat O
healthy I-Habitat B-Habitat
individuals I-Habitat I-Habitat
with I-Habitat I-Habitat
soft I-Habitat I-Habitat
stools I-Habitat I-Habitat
were O O
evaluated O O
. O O

Thirty O O
- O O
four O O
healthy B-Habitat O
adults I-Habitat O
who O O
had O O
soft B-Habitat O
stools I-Habitat O
were O O
randomised O O
into O O
2 O O
groups O O
, O O
and O O
the O O
effects O O
of O O
a O O
regular O O
4 O O
- O O
week O O
intake O O
of O O
probiotics B-Habitat O
were O O
evaluated O O
by O O
a O O
placebo O O
- O O
controlled O O
, O O
double O O
- O O
blind O O
, O O
parallel O O
- O O
group O O
comparative O O
design O O
. O O

Defecation O O
frequency O O
significantly O O
decreased O O
after O O
the O O
4 O O
- O O
week O O
intake O O
period O O
compared O O
with O O
before O O
the O O
probiotic B-Habitat O
treatment O O
. O O

The O O
stool B-Habitat O
quality O O
significantly O O
improved O O
( O O
hardened O O
) O O
compared O O
to O O
the O O
placebo O O
. O O

Also O O
, O O
the O O
water B-Habitat O
content I-Habitat O
of I-Habitat O
the I-Habitat O
stools I-Habitat O
was O O
lower O O
in O O
the O O
probiotic B-Habitat O
group I-Habitat O
than O O
in O O
the O O
placebo B-Habitat O
group I-Habitat O
. O O

Live O O
LcS B-Bacteria O
was O O
recovered O O
at O O
6 O O
. O O
9 O O
± O O
1 O O
. O O
3 O O
and O O
7 O O
. O O
2 O O
± O O
0 O O
. O O
8 O O
log O O
( O O
10 O O
) O O
CFU O O
per O O
1g O O
of O O
stool B-Habitat O
after O O
2 O O
and O O
4 O O
weeks O O
, O O
respectively O O
, O O
of O O
probiotic B-Habitat O
treatment O O
. O O

The O O
number O O
of O O
bifidobacteria B-Bacteria O
in O O
the O O
stools B-Habitat O
also O O
increased O O
significantly O O
compared O O
with O O
the O O
level O O
before O O
starting O O
the O O
probiotics B-Habitat O
. O O

The O O
organic O O
acid O O
levels O O
( O O
total O O
, O O
acetic O O
acid O O
, O O
propionic O O
acid O O
, O O
and O O
butyric O O
acid O O
) O O
significantly O O
increased O O
compared O O
with O O
the O O
level O O
before O O
intake O O
in O O
both O O
the O O
probiotic B-Habitat O
and O O
placebo B-Habitat O
groups I-Habitat O
, O O
but O O
they O O
returned O O
to O O
the O O
original O O
levels O O
after O O
the O O
end O O
of O O
the O O
intake O O
period O O
. O O

These O O
results O O
suggest O O
that O O
probiotic B-Habitat O
fermented I-Habitat O
milk I-Habitat O
beverage I-Habitat O
has O O
an O O
intestine B-Habitat O
- O O
conditioning O O
effect O O
by O O
improving O O
the O O
frequency O O
of O O
defecation O O
and O O
stool B-Habitat O
quality O O
and O O
increasing O O
the O O
intrinsic O O
bifidobacteria B-Bacteria O
in O O
healthy B-Habitat B-Habitat
individuals I-Habitat I-Habitat
with I-Habitat I-Habitat
soft I-Habitat I-Habitat
stool I-Habitat I-Habitat
. O O

A O O
cell O O
- O O
free O O
system O O
for O O
the O O
replication O O
fo O O
bacteriophage O O
M O O
- O O
13 O O
duplex O O
DNA O O
. O O

Cell O O
- O O
free O O
extracts O O
from O O
M O O
- O O
13 O O
am5 O O
infected O O
Escherichia B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
cells O O
which O O
are O O
highly O O
concentrated O O
on O O
cellophane B-Habitat B-Habitat
membrane I-Habitat I-Habitat
disks I-Habitat I-Habitat
replicate O O
efficiently O O
endogenous O O
M O O
- O O
13 O O
duplex O O
DNA O O
. O O

If O O
the O O
reaction O O
is O O
carried O O
out O O
in O O
the O O
presence O O
of O O
bromodeoxyuridine O O
triphosphate O O
, O O
the O O
majority O O
of O O
the O O
label O O
is O O
found O O
in O O
two O O
classes O O
of O O
hybrid O O
DNA O O
molecules O O
in O O
which O O
either O O
the O O
viral O O
or O O
the O O
complementary O O
strand O O
is O O
newly O O
synthesized O O
. O O

A O O
minor O O
portion O O
of O O
the O O
label O O
is O O
incorporated O O
into O O
fully O O
synthetic O O
duplex O O
DNA O O
. O O

DNA O O
synthesis O O
requires O O
ATP O O
and O O
is O O
inhibited O O
by O O
nalidixic O O
acid O O
, O O
novobiocin O O
, O O
and O O
arabinosylnucleoside O O
triphosphates O O
. O O

Rifampicin O O
blocks O O
preferentially O O
the O O
synthesis O O
of O O
molecules O O
with O O
labeled O O
complementary O O
strands O O
. O O

A O O
similar O O
effect O O
is O O
observed O O
upon O O
addition O O
of O O
the O O
helix O O
- O O
destabilising O O
M O O
- O O
13 O O
gene O O
V O O
protein O O
. O O

In O O
contrast O O
, O O
addition O O
of O O
E B-Bacteria B-Bacteria
. I-Bacteria I-Bacteria
coli I-Bacteria I-Bacteria
helix O O
- O O
destabilising O O
protein O O
( O O
Eco B-Bacteria O
HD O O
- O O
protein O O
) O O
stimulates O O
the O O
synthesis O O
of O O
both O O
types O O
of O O
hybrid O O
DNA O O
molecules O O
as O O
well O O
as O O
the O O
formation O O
of O O
fully O O
synthetic O O
duplex O O
DNA O O
. O O

Prevalence O O
of O O
thermotolerant O O
Campylobacter B-Bacteria B-Bacteria
in O O
partridges B-Habitat B-Habitat
( O O
Perdix B-Habitat O
perdix I-Habitat O
) O O
. O O

To O O
estimate O O
the O O
prevalence O O
of O O
thermotolerant O O
Campylobacter B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
. I-Bacteria O

in O O
commercially B-Habitat O
reared I-Habitat O
partridges I-Habitat O
( O O
Perdix B-Habitat O
perdix I-Habitat O
) O O
in O O
southern O O
Italy O O
. O O

Cloacal B-Habitat O
swabs I-Habitat O
of I-Habitat O
partridges I-Habitat O
( O O
n O O
= O O
240 O O
) O O
, O O
equally O O
distributed O O
between O O
male O O
and O O
female B-Habitat B-Habitat
birds I-Habitat I-Habitat
, O O
from O O
a O O
game B-Habitat O
bird I-Habitat O
farm O O
located O O
in O O
the O O
Southern O O
Italy O O
were O O
examined O O
for O O
the O O
prevalence O O
of O O
thermotolerant O O
Campylobacter B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
. I-Bacteria O

The O O
samples O O
were O O
processed O O
in O O
order O O
to O O
detect O O
thermotolerant O O
Campylobacter B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
. I-Bacteria O

by O O
culture O O
methods O O
. O O

The O O
positive O O
samples O O
were O O
then O O
confirmed O O
by O O
multiplex O O
polymerase O O
chain O O
reaction O O
. O O

Thermotolerant O O
Campylobacter B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
. I-Bacteria O

were O O
isolated O O
from O O
118 O O
( O O
49 O O
. O O
2 O O
% O O
) O O
of O O
the O O
240 O O
cloacal B-Habitat O
swabs I-Habitat O
examined O O
. O O

As O O
proved O O
by O O
PCR O O
, O O
100 O O
% O O
of O O
the O O
strains O O
were O O
identified O O
as O O
Campylobacter B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
( O O
118 O O
/ O O
118 O O
) O O
, O O
and O O
15 O O
( O O
12 O O
. O O
7 O O
% O O
) O O
out O O
of O O
the O O
118 O O
positive O O
samples O O
were O O
also O O
positive O O
for O O
Campylobacter B-Bacteria B-Bacteria
jejuni I-Bacteria I-Bacteria
. O O

In O O
contrast O O
, O O
Campylobacter B-Bacteria B-Bacteria
lari I-Bacteria I-Bacteria
was O O
not O O
identified O O
. O O

Adult B-Habitat O
partridges I-Habitat O
showed O O
a O O
significantly O O
higher O O
prevalence O O
( O O
P O O
< O O
0 O O
. O O
05 O O
) O O
than O O
younger B-Habitat O
ones I-Habitat O
. O O

These O O
results O O
reinforce O O
the O O
assumption O O
that O O
game B-Habitat O
birds I-Habitat O
may O O
be O O
considered O O
as O O
potential O O
carriers O O
of O O
Campylobacter B-Bacteria B-Bacteria
spp I-Bacteria I-Bacteria
. I-Bacteria O

for O O
human B-Habitat B-Habitat
being O O
and O O
other O O
animal B-Habitat O
species I-Habitat O
. O O

Although O O
an O O
earlier O O
1986 O O
publication O O
described O O
the O O
prevalence O O
of O O
Campylobacter B-Bacteria B-Bacteria
coli I-Bacteria I-Bacteria
in O O
commercially B-Habitat O
reared I-Habitat O
partridges I-Habitat O
, O O
this O O
is O O
the O O
first O O
report O O
to O O
confirm O O
the O O
species O O
of O O
Campylobacter B-Bacteria B-Bacteria
using O O
a O O
PCR O O
test O O
. O O
